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ABSTRACT 
The Appalachia region of the U.S. has noted socioeconomic disparities, elevated rates and 
mortality for many cancers, and substandard cancer treatment patterns. These disparities, 
combined with Appalachia’s largely rural population, suggest that the region has reduced access 
to health care. This research investigated the methodology behind spatial access to healthcare 
using population-based clinical data and geographic information systems (GIS) software. The 
dissertation’s goal was to provide a guide of the latest spatial access methods in Appalachia and 
to demonstrate how those methods can be incorporated into models studying cancer disparities in 
the region. Accredited mammography centers and primary care physicians in 2008 from 
Pennsylvania, Ohio, Kentucky, and North Carolina, along with U.S. Census population data, 
were geocoded into GIS software. Methods compared included ratios of mammography centers 
and physicians to county populations, travel time to closest mammography centers and 
physicians, and several versions of the newer two-step floating catchment area (2SFCA) method, 
which has never been evaluated in Appalachia. As a measure of predictive validity, spatial access 
methods were then used to predict two important breast cancer clinical indicators: stage at 
diagnosis and receipt of adjuvant hormonal therapy after a qualifying surgery. Urban and non-
Appalachia areas had consistently shorter travel times than the rural and Appalachia areas of the 
same states, across both travel times to mammography centers and primary care physicians. The 
2SFCA measures that included variable catchment sizes appeared distinct from the original 
2SFCA method and 2SFCA methods that included distance decay weights but no variable 
catchments. Predictors of late-stage breast cancer diagnosis included age, insurance status, 
xii 
county primary care to population ratio, and primary care 2SFCA score. Geographically 
weighted logistic regression revealed that the effect of the predictor variables varied throughout 
the study region. Predictors of adjuvant hormonal therapy included the presence of multiple 
diseases, county economic status, and mammography center 2SFCA score. Overall, the 2SFCA 
method with variable catchment sizes offered the greatest predictive validity of the access 
measures and offers theoretical improvements over the other access to care measures. 
Nonetheless, further research is needed to validate the 2SFCA method parameters with patient 
healthcare utilization data. 
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CHAPTER 1 
Introduction 
 
1.1 Statement of the Problem 
 Appalachia is a 205,000 square mile area that spans the Appalachian Mountains from 
southern New York to northern Mississippi. The region consists of parts of 13 states: Alabama, 
Georgia, Kentucky, Maryland, Mississippi, New York, North Carolina, Ohio, Pennsylvania, 
South Carolina, Tennessee, Virginia, and West Virginia. Appalachia lags behind national 
averages across many socioeconomic indicators (Pollard & Jacobsen, 2013). The percentage of 
high school and college graduates is less in Appalachia than nationally. Per capita income is less 
in Appalachia than nationally, and the percentage of Appalachian residents below the poverty 
line is also greater than national averages (Pollard & Jacobsen, 2013). Residents of Appalachia 
also engage in more risky health behaviors. Rates of smoking (Appalachia Regional 
Commission, 2008) and obesity (Herath & Brown, 2013) are higher in Appalachia than 
nationally. 
 In addition to the socioeconomic disparities, Appalachia residents suffer from an 
increased cancer burden. Since the early 1990s, the National Cancer Institute has recognized this 
burden and funded a network of community partners and academic researchers to reduce cancer 
health disparities in the region (Appalachia Community Cancer Network, 2013). Incidence of 
several cancers is higher in Appalachia than non-Appalachia parts of the same states and is 
higher in Appalachia than nationally. For example, Appalachia Kentucky, Ohio, and Virginia 
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have higher incidence of cervical cancer than non-Appalachia parts of those states (Appalachia 
Community Cancer Network, 2009). Appalachia Kentucky, Ohio, and Pennsylvania have higher 
incidence of colon cancer than non-Appalachia areas of those states (Appalachia Community 
Cancer Network, 2009). Appalachia Kentucky, Ohio, and Virginia also have higher incidence of 
lung cancer than non-Appalachia parts of those states (Appalachia Community Cancer Network, 
2009). The Appalachia region as a whole has a higher incidence rate of lung and colon cancer 
that the rest of the U.S. (Winger et al., 2003). 
 Cancer mortality is similar, with many cancers having higher mortality rates in 
Appalachia than non-Appalachia parts of the same states, and higher rates in Appalachia than 
nationally. The mortality rate for all cancers combined is higher in Appalachia than the rest of 
the U.S. (Blackley, Behringer, & Zheng, 2012). Mortality rates specifically for lung and 
bronchus cancer, colon cancer, and cervical cancer are also all higher in Appalachia than in non-
Appalachia states (Blackley, Behringer, & Zheng, 2012). Within Ohio, the Appalachia region 
has increased mortality rates for lung and bronchus cancer, colon cancer, cervical cancer, and 
melanoma skin cancer compared to the non-Appalachia region (Fisher et al., 2008). Disparities 
exist even for cancers where mortality rates are similar between Appalachia and non-Appalachia 
areas, such as female breast cancer. Breast cancer mortality rates are declining faster in non-
Appalachian counties in Appalachian states and in non-Appalachia national counties compared 
to Appalachian counties (Yao, Lengerich, & Hillemeier, 2012).  
 Consistent with these disparities, there is evidence that cancer treatment and screening is 
sub-optimal in Appalachia. Rates of the preferred early stage breast cancer treatment—breast 
conserving surgery and adjuvant radiation—are lower for Appalachian women than national 
rates (Freeman, Huang, & Dragun, 2012). Rates of mammograms and clinical breast exams, the 
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standard breast cancer screening tools, are lower for Appalachian women than among other U.S. 
women (Hall et al., 2002). Cervical cancer screening rates are also lower for Appalachian 
women compared to national rates (Hall et al., 2002). Outside of Appalachia there is a much 
larger body of research identifying substandard cancer care and implicating factors like race and 
ethnicity, urban or rural residence, and socioeconomic status. Much of this research uses data 
from the Surveillance, Epidemiology, and End Results (SEER) program, which largely excludes 
Appalachia. Kentucky was added to the SEER database in 2001 and is currently the only 
Appalachia area represented.    
 Cumulatively, the increased incidence, mortality, and examples of substandard care 
suggest that the Appalachia region has reduced access to cancer care (Pasket et al., 2011). Access 
to care refers to an individual’s ability to obtain the medical care they need (Gulliford et al., 
2002). Both spatial and non-spatial factors can impact access to care. Spatial factors focus on the 
geographic relationship between patient and healthcare provider. Measures like travel time or 
travel distance between patient and provider are examples of spatial factors. Non-spatial factors 
include socioeconomic and demographic variables such as household income, educational 
attainment, and insurance status. 
 Research both within and outside of Appalachia demonstrates that reduced access to care 
negatively impacts cancer outcomes. In England, for example, the likelihood of receiving 
recommended lung cancer care decreased as travel time to treatment providers increased (Jones 
et al., 2008). Among black women in Detroit, late stage breast cancer diagnosis was associated 
with greater travel distance to mammography facilities (Dai, 2010). An example of non-spatial 
factors is demonstrated by research showing that lung cancer patients with Medicaid insurance 
were less likely to receive recommended treatments than their peers with private insurance 
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(Harlen et al., 2005). In Appalachia Ohio, children without a regular primary care physician had 
poor general health, and the parents of those children reported that access to primary care was 
the contributing issue (Smith & Holloman, 2011).  
 This thesis focuses on the methodology behind the spatial, or geographic, component of 
access to care, often referred to as spatial access. The simplest method for measuring spatial 
access focuses on the density of healthcare providers. Here, researchers calculate the ratio of 
healthcare providers per population count in a defined geographic boundary. For example, the 
Department of Health and Human Services (DHHS) defines Health Professional Shortage Areas 
(HPSAs) as rational service areas where the population to primary care physician ratio is 3,500:1 
or higher (DHHS, 2013). Calculating travel time or travel distance between a patient and their 
healthcare provider is another relatively straightforward approach for measuring spatial access. 
Researchers input patients’ addresses and healthcare provider addresses into a geographic 
information systems (GIS) program and the software maps the addresses as latitude and 
longitude coordinates, a process called geocoding. A researcher can then determine if travel time 
to a healthcare provider impacts an outcome of interest, such as whether or not a patient received 
the latest recommended chemotherapy. 
 Both of these approaches—population to provider ratios and travel time—have 
limitations. Population to provider ratios use fixed geographic boundaries, such as census tracts 
or zip codes. If a resident lives in the center of the boundary, the approach may capture the 
providers they could reasonably access. But, residents who live near the edge of boundaries are 
likely to travel into a neighboring boundary to access health care (Guagliardo, 2004). Another 
issue is travel within boundaries. Population to provider ratios make no distinction between 
providers adjacent to a resident and providers located at the opposite boundary edge to the 
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resident. This missing feature is referred to as distance decay. Conversely, travel time or distance 
does capture distance decay. One provider is recorded as five minutes from a resident while 
another provider is 30 minutes from the resident. Travel time and distance measures are limited, 
however, by failing to account for supply and demand of providers and residents (Luo & Wang, 
2003). For example, two patients may each be 30 minutes from their closest provider, but one of 
the providers serves twice as many patients. The providers are similarly located (supply), but 
their demand is different.  
 The two step floating catchment area (2SFCA) method was designed to overcome these 
limitations (Wang & Luo, 2005). This method also begins by geocoding healthcare provider and 
population addresses into GIS software. The first step in the 2SFCA identifies each healthcare 
provider and calculates a population to provider ratio within a defined service area, or catchment, 
around that provider. For example, one provider may have 3,000 residents and 12 other providers 
in the one-hour travel time catchment area that surrounds them, while another provider may have 
500 residents and 10 other providers in their surrounding one-hour catchment area. The second 
step of the 2SFCA identifies each resident or group of residents (e.g., if census tract population 
data is being used) and searches for all the healthcare providers within that resident’s catchment 
area. Each provider found in a resident’s catchment area will have a corresponding ratio, 
calculated in step one. The patient’s spatial access score is found by summing all the ratios of the 
healthcare providers found within their catchment. Thus, the 2SFCA method overcomes the 
boundary problem of provider to population ratios by creating a new catchment for each provider 
and resident. Step one of the 2SFCA method overcomes the supply and demand problem of 
travel time measures by incorporating the ratio of residents to providers for each physician’s 
catchment area. 
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 Despite the improvements of the original 2SFCA method, there are noted limitations. 
Similar to traditional provider to population ratios, the 2SFCA method does not account for 
distance decay (Wang, 2012). If a catchment area is set as a travel time of 30 minutes, all 
providers within a 30 minute drive of a resident are considered equally accessible. This implies 
that residents are as likely to receive care from a provider 1 minute away compared to a provider 
30 minutes away. The other drawback of the original 2SFCA method is the fixed catchment size 
(Wang, 2012). In urban areas, defining a catchment as a 15 minute travel time might be 
appropriate, but in rural areas residents may regularly travel longer than 15 minutes for 
healthcare.  
   Enhancements to the 2SFCA method have addressed both problems. Researchers have 
added a weighting function to account for distance decay within catchments (Lou & Qi, 2009). 
The weighting function can be discrete, where every 10 minutes the weight will increase until the 
catchment limit is reached. If the catchment size was set as a 30 minute travel time, providers 
within 10 minutes of a resident might receive the highest weight because the resident has the best 
access to those providers. Providers between 10 and 20 minutes from a resident would receive a 
smaller weight, and providers between 20 and 30 minutes of a resident would receive the 
smallest weight. The weighting function can also be continuous, where the weight is applied 
smoothly across the entire 30 minute catchment size (Wang, 2012). Luo and Qi (2009) originally 
proposed the three distinct weights (corresponding to travel times of 0-10 minutes, 10-20 
minutes, and 20-30 minutes) without any empirical evidence that those travel times match 
healthcare utilization behaviors. There is a similar lack of empirical justification behind the 
choice of a continuous distance decay function. Researchers have implemented a continuous 
function to prevent the sudden weighting drop of at the end of each discrete travel zone, but how 
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quickly or slowly that function weights travel time has yet to be determined (McGrail, 2012). 
Wan et al. (2012) recently proposed a relative spatial access ratio (SPAR) for use when 
researchers do not have empirical evidence for distance decay. The method is mathematically 
simple—calculating the ratio between a census tract’s 2SFCA spatial access score and the mean 
of all census tract scores from the study area—but it did provide stable results across a variety of 
distance decay functions. This reduces the importance of choosing decay function parameters 
that mimic actual healthcare utilization behaviors, while still allowing for comparison between 
different geographic areas.    
 The other improvement to the 2SFCA method was the addition of variable catchment 
sizes (McGrail, 2012). Since there are two steps to the 2SFCA method, the catchments need to 
vary twice. First a catchment is determined for providers (referred to as the service catchment 
size), and then a catchment is determined for residents (referred to as the population catchment 
size). Some researchers suggest that the service catchment size should vary according to the 
setting the healthcare provider practices in (McGrail & Humphreys, 2009). This approach 
accounts for the reality that metropolitan providers are likely to service different size areas than 
rural providers. Other researchers suggest that the service catchment size should expand until a 
certain population to provider threshold is met (Luo & Whippo, 2012).  
There are also several options for varying the population catchment size. One possibility 
is to cap the population catchment size at a set number of providers (McGrail & Humphreys, 
2009b). If the cap is 50 providers, the catchment size for an urban resident may be a 15 minute 
driving time while the catchment size for a rural resident may be an hour driving time. Another 
approach is to use a population to provider ratio as the threshold, where the catchment size 
increases until a desired ratio (e.g., the HSPA ratio of 3,500:1) is reached (Luo & Whippo, 
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2012). As with the choice of distance decay functions, there is a lack of empirical justification 
for the different methods to vary catchment size. Ideally, researchers would determine both 
distance decay within catchments and catchment sizes by referencing medical claims data and 
clinical records to identify how far different proportions of patients travel to receive different 
types of care. Mao and Nekorchuk (2013) recently used data from a travel survey to determine 
that Florida households traveled on average 22.8 minutes for a medical or dental service, with 
the first quartile at 10 minutes and the third quartile at 30 minutes. They then set both the service 
and population catchment sizes at a max of 30 minutes travel time. Although the data collection 
and implementation were simplistic—for example, there was no distance decay within the 30 
minute catchment, the type of service was broadly defined, and the sample only included 118 
households—the technique is an example of using actual healthcare utilization behaviors to 
define the 2SFCA parameters. 
 Overall, cancer disparities in Appalachia warrant further research. Appalachia residents’ 
reduced access to healthcare contributes to those cancer disparities. Unfortunately, there is no 
published research on Appalachia residents’ access to care using the latest measure of spatial 
access, the 2SFCA method. This likely stems from the variety of functional parameters that the 
2SFCA offers and the lack of clear guidance as to which are most appropriate. As a result, 
research in Appalachia examining cancer disparities and access to care is not using the most 
comprehensive approach, thereby limiting the conclusiveness of its results.  
 
1.2 Nature of the Study 
 This thesis is a retrospective cohort study that investigates spatial access to care in the 
Appalachia region and its impact on breast cancer care. The research uses a linked dataset of 
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combined patient clinical and treatment information, healthcare provider geographic information, 
and census-level demographic information. Study participants are drawn from the Appalachia 
counties of Kentucky, North Carolina, Ohio, and Pennsylvania during the 2006-2008 calendar 
years.  
 Initially the thesis focuses on the methodology behind the measurement of spatial access 
to care. Population and provider locations in the study area were geocoded into GIS software. 
Population locations and counts are from Census blocks of the U.S. Census 2000 Tiger/Line 
files. Primary care physician locations are obtained from the American Medical Association 
(AMA) Physician Masterfile. Spatial access to more specialized cancer care is also evaluated. 
All U.S. Food and Drug Administration (FDA) accredited mammography facilities in the study 
area during 2008 are geocoded. Corresponding population counts and locations are drawn from 
Census block groups of the U.S. Census 2000 Tiger/Line files. Census block groups, instead of 
the smaller Census blocks, are used with the mammography facilities because block groups 
allow researchers to determine the population of women age 40 and above, which was the 
recommended age for mammography screening during the study years (U.S. Preventive Services 
Task Force, 2009). Census blocks are more precise because they cover a smaller area, but age 
and gender are not available at the block level. Thus, Census blocks are used when evaluating 
access to primary care physicians because all members of the population use primary care 
services and no further population distinctions are necessary. 
 Once population data and healthcare provider locations are input into GIS software, 
spatial access can be computed for each geographic boundary (i.e., Census blocks or Census 
block groups) in the study area. Access is determined using each of the methods referenced in 
section 1.1, including the traditional methods of population to provider ratios and travel time to 
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the nearest provider location, as well the 2SFCA method and its iterations. These methods will 
determine spatial access to primary care physicians and spatial access to mammography 
facilities. Spatial statistics were then used to evaluate each of the spatial access methods.  
 After identifying a best practice approach for measuring spatial access to care in 
Appalachia, I examine how access to care impacts breast cancer stage at diagnosis, an important 
clinical indicator for patient outcomes. I also examine how access to care predicts receipt of 
adjuvant hormonal therapy after breast cancer surgery. Street addresses of breast cancer patients 
from the Appalachia counties of Kentucky, North Carolina, Ohio, and Pennsylvania during 
2006-2008 were geocoded in GIS software and matched to corresponding Census blocks or 
Census block groups. Each patient is associated with the spatial access score computed for their 
corresponding Census designated geographic area. Regression modeling was used to examine 
whether spatial access to care predicts late-stage breast cancer diagnosis or receipt of adjuvant 
therapy. Additional predictor variables tested include provider characteristics, facility 
characteristics, patient socioeconomic data, and patient demographic data. The regression 
analysis serves as a measure of predictive validity for the recommended measure of spatial 
access. 
 
1.3 Study Aims 
 This research investigates spatial accessibility in reference to primary care, where travel 
times and service areas are smaller, and cancer care, where travel times and service areas are 
larger. I then apply the refined spatial accessibility methods to two cancer care questions in 
Appalachia: 1) How does spatial access to care impact stage of breast cancer at diagnosis? 2) 
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How does spatial access to care impact whether or not patients receive recommended adjuvant 
hormonal therapy? The following three objectives will achieve these goals: 
Aim 1: Investigate methods for determining spatial accessibility to cancer care in the 
Appalachia region and identify best practices for future research. 
Specialty health care, including cancer care facilities, often requires further travel than primary 
care, especially in rural areas (Huang et al., 2009). Using the 2SFCA method to measure spatial 
access to cancer care may require further refinement of distance decay and catchment size 
functions. This aim evaluates the following methods for determining spatial access to 
mammography centers in the Appalachia region: 1) provider to population ratios, 2) travel time 
to providers, 3) 2SFCA method with three distance decay functions (quick-step discrete 
weighting function, slow-step discrete weighting function, and a continuous weighting function) 
and two variable catchment size functions (McGrail, 2012), and 4) relative spatial access ratio 
(SPAR) derived from the 2SFCA method (Wan et al., 2012). The results will lead to a 
recommendation of the most appropriate method for measuring spatial access to cancer care as 
compared in Appalachia. 
 
Aim 2: Investigate methods for determining spatial accessibility to primary care in the 
Appalachia region and identify best practices for future research. 
Primary care access is a crucial component of population health (Guagliardo, 2009). Methods to 
measure spatial access to primary care in Appalachia must perform effectively across rural, 
urban, and suburban settings in a large geographic area. The same spatial access methods will be 
evaluated as in Aim 1. The results will lead to a recommendation of the best performing method 
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for measuring spatial access to primary care in Appalachia, with updated distance decay and 
catchment size functions if necessary. 
 
Aim 3: Apply recommended spatial accessibility method to examine how access to health 
care affects breast cancer stage at diagnosis and receipt of adjuvant hormonal therapy. 
Breast cancer stage at time of diagnosis is an important predictor for overall survival, with later 
staged diagnoses presenting fewer treatment options (Henry et al., 2011). There is controversy in 
the literature as to whether travel time is an important predictor of late stage diagnosis. A recent 
study examined the issue across 10 state cancer registries and found no impact of travel time, but 
failed to use the more rigorous 2SFCA method (Henry et al., 2011). Adjuvant hormonal therapy 
is recommended for hormone receptor positive patients after either breast conserving surgery or 
mastectomy, and was also evaluated as a predictor of guideline concordant treatment. Aim three 
will model breast cancer stage at diagnosis and receipt of adjuvant hormonal therapy as a 
function of access to care variables, including spatial accessibility determined from the 
recommended methods in aims one and two. This aim will generate separate models for access to 
primary care and access to mammography facilities.  
 
1.4 Significance of the Study 
 The significance of this work stems from the methodologies evaluated, the importance of 
the cancer care question investigated, and the broad potential applicability of the work. The 
recommended methodology has potential application to other disadvantaged population groups 
outside of Appalachia and to other cancer care and chronic disease outcomes within Appalachia. 
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 The 2SFCA method has never been used to study access to care in the Appalachia region, 
despite its improvements over existing methods. Research on cancer treatment and outcomes in 
Appalachia needs to employ current best practice approaches for measuring spatial access to 
care, particularly because poor access to care is often implicated in Appalachia’s cancer 
disparities. Here, I provide the groundwork for future public health researchers in Appalachia to 
use the most accurate methods for determining spatial access to care. 
 The research also addresses an unresolved cancer care question in Appalachia: How does 
access to cancer care impact stage of breast cancer diagnosis? Research in Kentucky determined 
that longer travel times to mammography facilities predicted later stage diagnoses (Huang et al., 
2009). Subsequent research across 10 states found no effect of travel time to mammography 
facility on breast cancer stage at diagnosis (Henry et al., 2011). In this thesis, I use the more 
rigorous 2SFCA method to examine the question. 
 The recommended methodology’s potential application to other disadvantaged population 
groups outside of Appalachia is also significant. Previous research has measured access to care 
for ethnic minorities, individuals with disabilities, veterans, and many other disadvantaged 
groups. Clarification of the most accurate measures for determining spatial access to care will 
assist research in each of those populations, potentially leading to health policy changes with 
positive impacts. The results of this thesis will assist further public health research on additional 
cancer and chronic disease outcomes within Appalachia. This research applies spatial access 
methods to breast cancer care, but access to care is implicated in treatments for many other 
cancers and chronic diseases in Appalachia. 
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CHAPTER 2 
Evaluating and Comparing Methods for Measuring Spatial Access to Mammography 
Centers in Appalachia 
 
2.1 Abstract 
Purpose 
This study evaluated spatial access to mammography centers in Appalachia using both traditional 
access measures and the two-step floating catchment area (2SFCA) method. Spatial Access to 
care was compared between urban and rural and Appalachia and non-Appalachia areas of the 
same states.  
Methods 
The study region included the entire states of Pennsylvania, Ohio, Kentucky, and North Carolina. 
Accredited mammography centers during 2008 and women age 45 and older at the census block 
group level were geocoded. Ratios of county mammography centers to women age 45 and older, 
driving time to nearest mammography facility, and various 2SFCA approaches were compared. 
Results 
Closest travel time measures favored urban areas. Mammography center to population ratios 
produced abrupt results based on rigid county boundaries. The 2SFCA method produced varied 
results depending on the parameters chosen. Overall, Appalachia areas had greater travel times to 
their 
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closest mammography center. Appalachia areas in OH and NC had worse 2SFCA scores than 
non-Appalachia areas of the same states. 
Conclusion 
Significant differences exist between 2SFCA measures depending on which function parameters 
are chosen. A relative 2SFCA approach, the spatial access ratio (SPAR) method, was 
recommended because it helped minimize the differences between various 2SFCA approaches. 
 
2.2 Introduction 
 The Appalachia region of the U.S. spans a 13 state region from Alabama to New York. 
The region has been designated as a special population of interest by the National Cancer 
Institute because of disparities in cancer outcomes and treatment patterns (Lane et al., 2012; 
Lengerich et al., 2005). An example of these disparities are higher mortality rates for lung and 
bronchus, colon, and cervical cancer (Blackley, Behringer, & Zheng, 2012); reduced 
mammography screening (Bhanegaonkar et al., 2012); and lower rates of breast conserving 
surgery, rather than mastectomy (Freeman, Huang, & Dragun, 2012). Human population in 
Appalachia is sparse, with 42 percent of the population classified as rural, as compared to a 
national average of 20 percent (ARC, 2014). The region also has a lower per capita income and a 
higher poverty rate than the national average (Pollard & Jacobson, 2014). Due to Appalachia’s 
rural population, distressed economic indicators, and mountainous terrain, reduced access to care 
has been implicated in the region’s cancer disparities (Paskett et al., 2011). 
 Access to care is a multidimensional concept that consists of both spatial and nonspatial 
factors. Nonspatial factors included age, socioeconomic status, and ethnicity, for example (Wang 
& Luo, 2005). Spatial access is focused on the geographic distribution of healthcare providers 
20 
and the populations they serve (Wang, 2012). Some researchers further distinguish between 
potential spatial access, referring to the geographic possibility that a service will be utilized, and 
realized access, which refers to the actual service used (McGrail, 2012). This study focuses on 
potential spatial access (further termed ‘spatial access’ for brevity.). 
 Traditionally, spatial access was calculated as a provider to population ratio, often using 
counties as the geographic boundaries (Wang, 2012). The method is simple to compute, 
requiring only population statistics (e.g., U.S. Census data) and the number of healthcare 
providers working in that county. The current Health Professional Shortage Area (HPSA) 
designation by the U.S. Department of Health and Human Services (DHHS) relies on this 
technique (DHHS, 2010). DHHS sets a threshold of one physician per 3,000 people in a rational 
service area to define HPSAs. With more widespread use of geographic information systems 
(GIS) technologies, researchers began using travel time or travel distance between population 
and providers as a measure of spatial access (Wang & Lou, 2005). This allowed more specificity, 
as individual patient and provider addresses could be geocoded into GIS software. 
 Although these two methods are the most widely used, they have noted limitations 
(Guagliardo, 2004). The fixed boundaries of provider to population ratios do not match real 
world healthcare utilization. Ratios also fail to account for travel impediments within their fixed 
boundary, giving equal weight to providers and populations on opposite ends of a boundary as 
those geographically close. While travel time or distance GIS calculations overcome the latter 
problem of travel impediments, the calculations fail to capture the supply and demand element of 
healthcare.  
 The two-step floating catchment area (2SFCA) has emerged as an additional measure of 
spatial access to care that overcomes some of the limitations of the original methods (Luo & 
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Wang, 2003; Wang & Luo, 2005). The first step of the 2SFCA identifies the populations that 
each healthcare provider serves. This area is called a catchment and can range from a 30 to 60 
minute travel time, or longer, depending on the type of care. A provider to population ratio is 
computed for each physician’s catchment. Step two moves to each population area and searches 
for all service providers within that population’s catchment, also set at 30 to 60 minutes, or 
longer. The step one ratios within a population’s catchment are then summed, resulting in an 
access score for each population location. 
 There are limitations to the original 2SFCA method, however (Luo & Whippo, 2012; 
Wang, 2012). The step one and step two catchments still suffer from the boundary problem 
described for traditional provider to population ratios. For some service providers a 30 minute 
catchment may be accurate, but others will serve a smaller area (downtown urban providers) or 
larger area (rural community providers). Also, within the step one and step two catchments, the 
original 2SFCA fails to account for travel impediments, also termed distance decay. During step 
one, for example, a population 5 minutes from a provider is deemed as likely to use the service 
as a population 25 minutes away.  
 In response to these limitations, several researchers have modified the original 2SFCA 
(Luo & Qi, 2009; McGrail & Humphreys, 2009). A distance decay function was added to 
distinguish between different geographic distances within a catchment. The catchment can be 
broken into distinct zones (e.g., 0-10 min., 10-20 min, 20-30 min.), with a unique weight applied 
at each zone (Luo & Qi, 2009). A continuous function has also been used (McGrail & 
Humphreys, 2009) where there is no drop at the end of the zone. Weights are applied smoothly at 
each increase in travel time or distance. Another addition has been the use of variable catchment 
sizes. One technique is to define a desired provider to population ratio (e.g., 1:3,000) and expand 
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a catchment until that ratio is met (Luo & Whippo, 2012). Another technique is to cap the 
number of providers a population can access (e.g., 100), and when that limit is reached the 
catchment ends (McGrail & Humphreys, 2009). Taking a different approach, another group of 
researchers (Wan et al., 2012) created the spatial access ratio (SPAR) score, which can use any 
of the modified 2SFCA methods mentioned by taking a population’s (i.e., census tract) 2SFCA 
score and dividing it by the mean 2SFCA score of an entire region. The SPAR score represents a 
relative comparison that may be useful when researchers are unsure how much of a travel 
impediment exists and therefore which decay weights to use (Wan et al., 2012). 
 The 2SFCA method, despite its noted benefits, has never been used to study access to 
care in Appalachia. Outside of Appalachia, only a limited amount of research has compared and 
contrasted the effects of the newer 2SFCA parameters (i.e., distance decay and variable 
catchment sizes) on resulting access to care scores (McGrail, 2012; Wang, 2012). These 
comparisons generally occur in the context of primary care. Thus, researchers in Appalachia who 
study spatial access to more specialized cancer care need guidance on which methods are most 
appropriate and which parameters to choose.   
  The primary goal of this study was to explore patterns of potential spatial access to 
mammography centers in Appalachia. We compared results across the measures of provider to 
population ratios, travel times between populations and providers, and the newer 2SFCA 
method. Within the 2SFCA method, we compared the effects of added distance decay functions 
and variable catchment sizes on the resulting access scores. Finally, we evaluated the differences 
in access to mammography centers between Appalachia and non-Appalachia areas of the same 
states, using all three spatial access measures. 
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2.3 Study area and data 
 We focused on a four state region of Appalachia: PA, OH, KY, and NC. All U.S. Food 
and Drug Administration (FDA)-accredited non-mobile mammography facilities in the four 
states during the year 2008 were obtained. There were 1,181 mammography centers in the four 
state study region, and each center had a street address that was able to be geocoded into GIS 
software. We did not include mammography centers of bordering states, which can affect access 
scores of populations near state borders. 
 Population data were extracted from the 2010 U.S. Census at the census block group 
level. Block groups usually have between 600 and 3,000 people, with an ideal size of 1,500. 
Much prior research measuring spatial access to care aggregated population data at larger 
geographic areas, generally zip codes (Dai, 2010) and census tracts (Wan et al., 2012). Using 
census block groups is more computationally intensive but allows greater precision in geographic 
estimation. Following previous research (Luo & Wang, 2003), we used the population weighted 
centroid of each block group, rather than the geographic centroid (U.S. Census Bureau, 2014). 
Centroid locations are given as latitude and longitude, which allows for integration into GIS 
software. Unlike mammography centers, we did include populations in neighboring states to 
simulate more accurate spatial access along state borders. We explore this edge effect in greater 
detail in the discussion. 
 The Appalachia Regional Commission’s (ARC) county designations were used to 
distinguish Appalachia and non-Appalachia areas. There were 28,418 total block groups, 
although only 28,357 had residents. Of those, there were 8,707 block groups in Appalachia 
regions of the four states and 19,650 block groups in non-Appalachia regions. There were 
10,717,421 people living in Appalachia regions and 27,392,443 people living in non-Appalachia 
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regions. Further designation of rural and non-rural areas was used when comparing spatial access 
scores. Urban-rural designation was done by census tract, with census RUCA codes of 7-10 
considered rural and codes 1-6 considered urban-suburban (Weeks et al., 2004). The rural 
population was 2,971,896 people and the urban population was 35,137,968 people. We used 
descriptive statistics and t-tests to compare access scores between Appalachia and non-
Appalachia regions and between rural and urban regions. 
 
2.4 Methodology 
Provider to population ratios 
 We calculated provider to population ratios at the county level. The number of 
mammography centers in each county was divided by the population of women age 45 and older 
in that county. Guidelines called for mammography screening beginning at age 40 (U.S. 
Preventive Service Task Force, 2009). However, the 2010 Census used age groups 35-44 and 45-
54. We chose to use women age 45 and older, consistent with prior research (Anderson et al., 
2014). Each census block group, our primary unit of analysis, was then assigned a county ratio 
based on the geographic county it resided in. 
Travel time 
 Mammography centers and census block groups were geocoded into ArcGIS (Version 
10.1, ESRI Inc., Redlands, CA). We used the Origin-Destination (OD) cost matrix function of 
the ArcGIS Network Analyst extension to compute travel times between the population weighted 
centroid of each block group and each mammography center, only including pairs within one 
hour of each other. A recent 10-state cancer registry study (Henry et al., 2011) with over 160,000 
breast cancer patients found that the average travel time to a patient’s diagnosing mammography 
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facility was 16.5 minutes and 97% of patients lived within one hour of their diagnosing facility. 
Along with travel time to the closest facility, we also computed the average travel time to the 
three closest facilities. 
Two-step floating catchment area 
  The first step of the original 2SFCA method identifies all populations (k) within a service 
provider’s (j) maximum catchment (do), set as a maximum of 60 minutes driving time. Although 
other 2SFCA mammography studies have used a 30 minute maximum catchment size (Lian et 
al., 2012), we felt the rural nature of Appalachia warranted a 60 minute maximum catchment size 
(McGrail & Humphreys, 2009). A population to provider ratio (Rj) was then computed using the 
total service providers (Sj) and total population (Pk) within catchment j: 
 Step 1: Rj = Sj  / ∑k ∈	{djk < do} Pk 
 Step 2 of the 2SFCA identifies all service providers (j) within the maximum travel time 
(do) of a population location (i) and sums all of the eligible service providers’ step 1 ratios (Rj), 
resulting in that population location’s access score (Ai): 
 Step 2: Ai = ∑ j ∈	{dij < do} Rj 
 We also examined three additional versions of the 2SFCA. The first included an added 
distance decay function across catchment time zones (Luo & Qi, 2009). Catchments were 
divided into four time zones: 0-10 minutes, 11-20 minutes, 21-30 minutes, and 31-60 minutes. 
Weights were applied at each zone in order to simulate the travel impediment as travel time 
increased. We used fast-step weightings and slow-step weightings, chosen from prior research 
(McGrail, 2012; Wan et al., 20120): 
 Fast-decay weights (w) = 1, 0.60, 0.25, 0.05 
 Slow-decay weights (w) = 1, 0.80, 0.55, 0.15 
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 Thus, each population location (k) in step one and each physician ratio (Rj) during step 
two are discounted by an above weight, depending on the travel time between population and 
provider (i.e., above weights correspond to 0-10, 11-20, 21-30, and 31-60 minute time zones): 
 Step 1: Rj = Sj / ∑k ∈	{djk < do} Pk w 
 Step 2: Ai = ∑ j ∈	{dij < do} Rj w 
 The second version of the 2SFCA we examined included both distance decay weights 
and varying catchment sizes. For step one of the 2SFCA, we used local population characteristics 
to determine how far to expand a service provider’s catchment, and thereby whether or not to 
apply the distance decay weights mentioned above (McGrail & Humphreys, 2009b). If a 
population was within 10 minutes of a service provider, no decay weight was applied. If the 
service provider was one of the five closest providers, no weight was applied because that 
provider will likely provide service to populations with few other choices. Prior research 
(McGrail & Humphreys, 2009b) set this limit to the closest 25 services, but that study examined 
primary care, not mammography centers, which are less abundant. Finally, if the service 
provider’s town population was greater than 5,000 and the population center’s town population 
was less than half of the service provider’s, no weight was applied. This rule represents 
situations where the service provider is in a larger town that likely provides services to smaller 
nearby communities. To estimate town populations, we linked mammography centers and census 
block groups with their closest Census Designated Place (CDP). CDPs are meant to represent the 
settled concentration of populations as either a city, town, village, or borough, and can cross 
county boundaries (U.S. Census Bureau, 2014). For step two of the 2SFCA, we capped the 
number of services a population center could access at 20. Thus, the first 20 services were 
weighted according to the distance decay rules above, but services after the first 20 closest were 
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not included in that population’s catchment. The cap represented the point where additional 
services do not offer increasing access. Again, prior primary care research set this cap at 100 
(McGrail & Humphreys, 2009), but due to lesser numbers of mammography centers we set the 
cap at 20.  
 When evaluating the combination of 2SFCA distance decay and variable catchment sizes, 
we also included a continuous decay weighting scheme to contrast with the slow-decay and fast-
decay weights (McGrail & Humphreys, 2009). The continuous weighting scheme followed the 
same rules and caps as above. But, when travel times (d) between population and provider were 
greater than 10 minutes and less than 60 minutes, and a slow or fast-decay weight would be 
applied, the following continuous weighting (w) was applied instead: 
 Continuous-decay weights (w) = ((60-d) / (60-10)) ^ 1.5 
 The final 2SFCA version we considered was the spatial access ratio (SPAR) score (Wan 
et al., 2012). SPAR was created in response to the subjectivity of distance decay weights and 
varying catchment sizes. SPAR is simple to calculate, being the ratio between a block group’s 
2SFCA score and the mean of all block group 2SFCA scores. 
 In sum, each census block group was assigned 10 spatial access scores for comparison: 1) 
County mammography facility to women age 45 years and older ratio; 2) Travel time to closest 
mammography center; 3) Original 2SFCA score; 4) Slow-decay 2SFCA score; 5) Fast-decay 
2SFCA score; 6) Slow-decay and variable catchment 2SFCA score; 7) Fast-decay and variable 
catchment 2SFCA score; 8) Continuous-decay and variable catchment 2SFCA score; 9) Slow-
decay and variable catchment SPAR score; 10) Fast-decay and variable catchment SPAR score. 
We mapped spatial access scores over their geographic area to visualize the resulting access 
within our study region. 
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2.5 Results 
  The regions with the highest population density included Philadelphia and surrounding 
southeastern Pennsylvania; the Pittsburgh area of western Pennsylvania; the Ohio cities of 
Cleveland, Akron, Columbus, and Cincinnati; Louisville and Lexington in Kentucky, and the 
smaller cities of central North Carolina (Fig. 2.1). The least populated areas were north central 
Pennsylvania and eastern Kentucky.   
   Spearman correlations were statistically significant between each of the 10 spatial access 
measures (Table 2.1). Increases in the provider to population ratio and the 2SFCA scores signal 
increasing spatial access, thus the negative correlation of both those measures with travel time to 
the closest mammography center, where decreasing travel times signal increasing spatial access. 
Travel time and population to provider ratio had the weakest correlation (rho = -0.115). Slightly 
stronger correlations occurred between travel time and the 2SFCA measures (-0.522 ≤ rho ≤ -
0.180) and between provider to population ratio and the 2SFCA measures (0.351 ≤ rho ≤ 
0.5450). Expectedly, the strongest correlations occurred between the various 2SFCA scores. The 
original 2SFCA score had a moderately strong correlation (0.599 ≤ rho ≤ 0.753) with the 
modified 2SFCA approaches, while each of the modified 2SFCA approaches were strongly 
correlated (0.777 ≤ rho ≤ 1).  
 County provider to population ratios are shown in Figure 2.2, with darker colors 
representing larger ratios in the higher quintile groups, and therefore greater spatial access. Many 
of the highest scores are found in Kentucky, where lower populations result in higher ratios. 
 The largest population centers—the Pittsburgh and Philadelphia regions—have mediocre 
scores, despite having the greatest number of mammography facilities. Rigid boundary 
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differences are present, especially in Kentucky, where scores from the largest and smallest 
quintiles border each other. 
 The largest driving times between census block groups and their closest mammography 
facility occurred in north central Pennsylvania, eastern Ohio, and eastern Kentucky (Fig. 2.2). 
The Cleveland-Akron to Pittsburgh corridor, the Philadelphia area, and central North Carolina 
had the shortest travel times. The shortest travel time measure had more gradual transitions from 
higher to lower access, compared to the county ratio measure. 
 The census block groups with the highest original 2SFCA scores were in the Cleveland-
Akron-Pittsburgh corridor, as well as central and eastern Kentucky (Fig. 2,3a). When slow (Fig. 
2.3b) and fast (Fig. 2.3c) distance decay functions were added, higher access scores became 
more dispersed and less clustered in contiguous areas, with the greatest difference occurring 
between the original and fast-decay 2SFCA scores. The differences were more subtle when 
varying the catchment sizes on the slow-decay (Fig. 2.3d) and fast-decay (Fig 2.3e) scores. For 
the slow-decay scores, using a variable catchment decreased access in the northern corridor of 
Cleveland-Youngstown-Pittsburg because populations were only allowed to access the first 20 
providers. These metropolitan areas had more than 20 mammography centers (e.g., the greater 
Pittsburgh area has about 60), and without a limit on the number of providers their populations 
can access their scores increase. Conversely, using variable catchments comparatively increased 
the slow-decay access for the NC cities Greensboro and Charlotte because those cities do not 
have a surplus of mammography centers (e.g., the greater Greensboro area has about 20), and 
thus their access scores did not drastically decrease when limiting catchment sizes. 
The most noticeable difference when varying catchment sizes within fast-decay scores 
(Fig. 2.3e) was reduced access in northwest Ohio, the Youngstown-Pittsburg corridor, and rural 
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central PA. Using a continuous-decay function along with varying catchments (Fig. 2.3f) 
resulted in scores more similar to the slow-decay and variable catchment 2SFCA scores, rather 
than the fast-decay and variable catchment 2SFCA scores. The greatest difference with the 
continuous-decay scores was the increase in scores throughout much of NC. The difference 
between slow-decay, variable catchment and fast-decay, variable catchment SPAR scores 
mirrored the differences between their corresponding 2SFCA scores, despite previous evidence 
of SPAR scores being robust against changes in decay weightings (Wan et al., 2012). 
 It is also helpful to compare the actual change in value for a 2SFCA score at the same 
population center after changing the decay weighting scheme. Figure 4 plots the different 2SFCA 
and SPAR values at each census block group by the varying slow- and fast-decay weightings. 
When using only the distance decay approach (Fig. 2.4a), there was no uniform increase or 
decrease based on slow or fast decay weightings. The only exceptions were the highest outlier 
scores, where the fast-decay weighting always increased scores. The distance decay and variable 
catchment size approach (Fig. 2.4b) produced a uniform result where nearly all block groups had 
reduced scores when using the fast-decay, variable catchment technique. The SPAR distance 
decay and variable catchment approach (Fig. 2.4c) moderated scores to some extent, compared to 
the similar 2SFCA approach, but a noticeable decrease in scores after using the fast decay, 
variable catchment technique still occurred for a majority of block groups. 
 Figure 2.5 distinguishes between urban and rural census block groups when comparing 
the change in value for 2SFCA scores after changing the decay weighting scheme. The most 
noticeable difference is that the highest scores across each approach were always from rural 
block groups (the scales are the same between urban and rural). The lower population pressure of 
rural areas in step one of the 2SFCA likely results in their increased scores compared to urban 
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areas. For urban block groups, the SPAR distance decay and variable catchment approach (Fig. 
5f) was closer to achieving its intended effect of not letting decay weights uniformly impact 
scores. For rural block groups, however, scores were uniformly decreased with the fast-decay, 
variable catchment technique (Fig. 2.5e). Mammography centers are generally farther distances 
from rural block groups, thus faster decay weightings appear to have more impact. 
 Continuing with the urban-rural divide, Table 2.2 compares the mean values across all 
spatial access measures between urban and rural block groups. Rural block groups had a higher 
provider to population ratio across each state. Conversely, travel time to the closest 
mammography center favored urban block groups, who on average had between an 11.15 minute 
(PA) and 6.17 minute (KY) shorter travel time than rural block groups. In PA, the 2SFCA and 
SPAR measures were either very similar between urban and rural block groups, or urban block 
groups had larger scores (e.g., slow-decay 2SFCA and fast-decay 2SFCA). In OH and NC, 
scores were higher for urban block groups across each 2SFCA and SPAR measure. In KY, rural 
block groups generally had larger scores, with the exception of the fast-decay, variable 
catchment 2SFCA and the fast-decay, variable catchment SPAR. Kentucky’s urban areas are 
smaller than the other study states, and the increasing population demands are not balanced with 
substantially greater numbers of mammography centers. 
 Finally, the mean values of spatial access scores between Appalachia and non-Appalachia 
block groups were compared (Table 2.3). Appalachia block groups had a higher provider to 
population ratio across each state, similar to the rural block groups in Table 2.2. Travel time, 
though, was greater for Appalachia areas, ranging from an increase of only 1.02 minutes in NC 
to 7.23 minutes in KY. In PA and KY, Appalachia block groups had higher 2SFCA and SPAR 
scores than non-Appalachia block groups. The difference in scores was closer in OH, but 
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generally the non-Appalachia scores were higher. In NC, all 2SFCA and SPAR measures were 
higher in non-Appalachia block groups.  
 
2.6 Discussion 
 Substandard access to care is implicated in cancer incidence and treatment patterns 
throughout Appalachia, yet no prior studies have evaluated the latest spatial access to care 
measures in the region. This study evaluated spatial access methods across a four-state region of 
Appalachia, compared differences between measures, and evaluated access between Appalachia 
and non-Appalachia areas of the same states. All access measures were significantly correlated 
with each other, although the strongest correlations occurred between variations of the 2SFCA 
method. Measuring travel time to closest mammography centers produced expected results. 
Urban-core areas were all within 10 minutes of their closest mammography center, while rural 
parts of north central PA, eastern OH, and eastern KY comprised the majority of areas with 
travel times greater than 40 minutes. Appalachia populations across each state had longer 
average travel times than non-Appalachia populations. Provider to population ratios were more 
unpredictable and abrupt. Adjacent areas of rural KY, for example, comprised the lowest and 
highest quintile scores because of rigid county boundaries. Clear geographic differences emerged 
when comparing the various iterations of the 2SFCA method. It was difficult, however, to 
discern easily identifiable patterns corresponding to the 2SFCA parameters because of the study 
region’s size and varying population distribution. 
  A consistent finding of the original 2SFCA, in regards to primary care physicians, was 
that urban areas had the highest access scores (Wang & Luo, 2005). In regards to mammography 
centers in Appalachia, our results partly confirm this trend. Urban areas in western PA, 
throughout Ohio, and in central NC all had among the highest original 2SFCA access scores. The 
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largest urban area, the Philadelphia region, contradicted that trend with mostly poor to moderate 
scores. Also surprising was that rural eastern KY comprised a large portion of the highest access 
scores, likely because of the low population density and a geographically consistent distribution 
of mammography centers through the state.  
 The concept of distance-decay weights within catchments was originally proposed 
because researchers wanted to limit accessibility at the edge of physician catchments, which 
often occurred between major population centers (Luo & Qi, 2009). In our original 2SFCA 
scores, for example, the entire corridor between northeastern OH cities received the highest 
quintile of access scores. After adding distance-decay weights, though, distinct regions of lower 
access suburban and rural areas emerged between these urban areas, particularly when using 
faster decay weights. 
 When creating methods to vary catchment sizes in the 2SFCA approach, researchers 
wanted to further refine access scores, especially in rural areas (Luo & Whippo, 2012; McGrail, 
2012). Within a realistic outer limit (e.g., 60 minutes), a rural population should be expected to 
travel farther for a service if that service is one of only several available. Following McGrail 
(2012), we did not apply distance decay weights for those closest provider and population 
connections when evaluating the total population that a provider serves. Our distance decay, 
variable catchment 2SFCA scores changed accordingly. In rural areas of each study state, mean 
access scores decreased when adding the variable catchments compared to only using distance-
decay weights. Providers were assumed to serve more rural populations, thus the step 1 2SFCA 
provider-to-population ratios were lower. In step 2, summed provider ratios around each 
population center were lower, resulting in lower overall access scores. 
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 Wan et al. (2012) created the SPAR technique due to the lack of guidance in the 2SFCA 
method for choosing decay weights within catchments. Across a nine county region of Texas, 
they showed that SPAR scores remained comparatively stable between populations despite using 
different decay weights. They applied SPAR to a 2SFCA model using only distance decay, not 
variable catchments, and in reference to primary care. Our application of SPAR in Appalachia to 
a distance decay, variable catchment model focusing on mammography centers largely achieved 
SPAR’s intended effect. For urban populations, which represented 92% of our study population, 
the SPAR technique reduced the effects of choosing between a fast or slow decay weight. (Our 
urban-rural classification placed many suburban areas in the urban category, for simplicity.) For 
these urban populations, there was no standard increase or decrease in SPAR scores 
corresponding to fast or slow decay weights. Conversely, for rural populations, moving from the 
slow to fast distance-decay, variable catchment SPAR technique resulted in a uniform decrease 
in scores. The average travel time to the closest mammography center for rural census block 
groups ranges from approximately 14 to 18 minutes, per state, which is outside of the initial 10 
minute zone where no distance decay is applied. For urban block groups the average times to the 
closest center are all approximately less than 10, making the choice of fast or slow decay weights 
irrelevant. We hypothesize that this population feature makes the SPAR technique less effective 
for rural block groups in our study region. 
Conceptually, our study had a number of strengths. To the best of our knowledge, it is the 
first time that the 2SFCA method has been used for Appalachia. Modern GIS software is making 
spatial access to care easier to measure, and public health research in the region needs to 
incorporate the latest techniques. Within broader work on the 2SFCA method, this study adds to 
a growing body of research applying the 2SFCA method to cancer care, rather than primary care 
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(Diad, 2010; Lian et al., 2012; Wan et al., 2012). Methodologically, our study benefited from the 
use of a smaller population area (census block group) than many previous studies that used either 
zip code areas or census tracts when employing the 2SFCA method (Wang, 2012). Although 
more computationally intensive, this technique provided more specificity when interpreting 
results. Another methodological strength was our inclusion of variable catchment sizes, which 
are both a theoretical and empirical improvement over distance-decay functions alone. Many 
studies published since the creation of variable catchment sizes did not utilize the technique 
(Lian et al., 2012; Mao & Nekorchuk, 2013; Tao et al., 2014).  
There were some important limitations to this study. We included populations from 
bordering states when computing service catchments in step 1 of the 2SFCA, but we did not 
include mammography centers from bordering states. This likely created an edge effect in our 
study region, particularly when adjacent urban areas likely included many additional 
mammography facilities (e.g., in New Jersey and Delaware for populations in Philadelphia). In 
other rural areas, such as western NC, there are unlikely to be many neighboring mammography 
centers along the rural Tennessee border. Another methodological limitation was our lack of 
information about the actual capacity of each mammography center. It is plausible that urban 
facilities have the capacity to serve many more women simultaneously than smaller rural 
facilities. By not including this distinction, there is a possibility that we underestimated 2SFCA 
access scores in urban areas. This omission may explain the Philadelphia region’s mediocre 
2SFCA scores.  
Another limitation, and an area we believe warrants additional research, concerns our 
lack of representative patient healthcare utilization data. It is generally agreed that the 2SFCA 
needs to include travel impediments and service area variability (McGrail, 2012). Yet, the choice 
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of which distance-decay weight to apply, or how to vary catchment sizes, is arbitrary. For 
instance, research needs to empirically validate that a service provider 40 minutes from a 
population should receive 1/12th of the weight of a provider 15 minutes away, as our fast-decay 
weighting scheme assumed. Similarly, it is difficult to decide where to cap the number of 
services that a population will consider, as we did when using 20 mammography centers as the 
upper limit when varying catchment sizes.  
In conclusion, we recommend the SPAR technique when researchers do not have data on 
how far their study population travels or what their population’s travel preferences are. The 
SPAR technique, particularly for urban and suburban areas, reduces the impact of choosing a 
faster or slower weighting.  
37 
2.7 References 
Anderson RT, Yang TC, Matthews SA, Camacho F et al. (2014). Breast Cancer Screening, Area 
Deprivation, and Later-Stage Breast Cancer in Appalachia: Does Geography Matter?. 
Health Services Research, 49: 546–567. 
Appalachia Regional Commision (ARC) The Appalachia region. [Accessed October 10, 2014]. 
Available at: http://www.arc.gov/appalachian_region/TheAppalachianRegion.asp   
Bhanegaonkar A, Madhavan S, Khanna R, & Remick SC (2012). Declining mammography 
screening in a State Medicaid Fee-for-Service Program: 1999–2008. Journal of Women’s 
Health, 21(8): 821–829. 
Blackley D, Behringer B, & Zheng S (2012). Cancer mortality rates in Appalachia: descriptive 
epidemiology and an approach to explaining differences in outcomes. J Community 
Health. 37(4): 804-813. 
Dai D (2010). Black residential segregation, disparities in spatial access to health care facilities, 
and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place. 16(5), 1038–
1052. 
Department of Health and Human Services (2008). Shortage Designation: Health Professional 
Shortage Areas & Medically Underserved Areas/Populations [Accessed October 15, 
2014]. Available at: http://www.hrsa.gov/shortage/ 
Freeman AB, Huang B, & Dragun AE (2012). Patterns of Care With Regard to Surgical Choice 
and Application of Adjuvant Radiation Therapy for Preinvasive and Early Stage Breast 
Cancer in Rural Appalachia. Am J Clin Oncol. 35(4): 358-63. 
Guagliardo MF (2004). Spatial accessibility of primary care: concepts, methods and challenges. 
Int J Health Geogr. 3:3. 
38 
Henry KA, Boscoe FP, Johnson CJ, Goldberg DW, Sherman R, & Cockburn M (2011). Breast 
cancer stage at diagnosis: Is travel time important? J. Community Health. 1;36:933–942. 
Lane N, Konrad R, Ricketts T et al. (2012). Health Care Costs and Access Disparities in 
Apppalachia. Washington, DC: Appalachia Regional Commission. 
Lengerich EJ, Tucker TC, Powell RK et al. (2005). Cancer Incidence in Kentucky, Pennsylvania, 
and West Virginia: Disparities in Appalachia. Journal of Rural Health. 21(1): 39–47. 
Lian M, Struthers J, & Schootman M (2012). Comparing GIS-Based Measures in Access to 
Mammography and Their Validity in Predicting Neighborhood Risk of Late-Stage Breast 
Cancer. PLoS ONE. 7(8): e43000. doi:10.1371/journal.pone.0043000. 
Luo W & Qi Y (2009). An enhanced two-step floating catchment area (E2SFCA) method for 
measuring spatial accessibility to primary care physicians. Health Place. 15:1100–1107. 
Luo, W & Wang F (2003). Measures of spatial accessibility to health care in a GIS environment: 
synthesis and a case study in the Chicago region. Environment and Planning B. 30(6): 
865–884. 
Luo W & Whippo TL (2012). Variable catchment sizes for the two-step floating catchment area 
(2SFCA) method. Health Place. 18:789–795. 
Mao, L. & Nekorchuk, D. (2013). Measuring spatial accessibility to healthcare for populations 
with multiple transportation modes. Health Place. 24:115-122. 
McGrail MR & Humphreys JS (2009). The index of rural access: an innovative integrated 
approach for measuring primary care access. BMC Health Serv Res. 9:124. 
McGrail MR & Humphreys JS (2009b). A new index of access to primary care services in rural 
areas. Aust NZ J Pub Health. 33:418–423. 
39 
McGrail MR (2012). Spatial accessibility of primary health care utilising the two step floating 
catchment area method: an assessment of recent improvements. Int J Health Geogr. 
16:11-50. 
Paskett ED, Fisher JL, Lengerich EJ et al. (2011). Disparities in underserved white populations: 
the case of cancer-related disparities in Appalachia. Oncologist. 16(8): 1072-81.  
Pollard K & Jacobson LA (2014) The Appalachian Region: A Data Overview from the 2008-
2012 American Community Survey. Appalachia Regional Commission. Retrieved from 
http://www.arc.gov/research/researchreportdetails.asp?REPORT_ID=109. 
Tao Z, Cheng Y, Dai T, & Rosenberg MW. (2014). Spatial optimization of residential care 
facility locations in Beijing, China: maximum equity in accessibility. International 
Journal of Health Geographics. 14:13-33.  
U.S. Census Bureau (2014). Centers of Population [accessed June 5, 2014]. Available at: 
https://www.census.gov/geo/reference/centersofpop.html 
U.S. Census Bureau (2014). Geographic Terms and Concepts – Place [Accessed June 5, 2014]. 
Available at: https://www.census.gov/geo/reference/gtc/gtc_place.html 
U.S. Preventive Services Task Force. (2009). Screening for breast cancer: U.S. Preventive 
Services Task Force recommendation statement. Ann Intern Med. 151: 716–726, W-236. 
Wan N, Zhan FB, Zou B, & Chow E (2012). A relative spatial access assessment approach for 
analyzing potential spatial access to colorectal cancer services in Texas. App Geography. 
12:291–299. 
Wang F (2012). Measurement, Optimization, and Impact of Health Care Accessibility: A 
Methodological Review. Ann Assoc Am Geogr. 102(5): 1104–1112. 
40 
Wang F & Luo W (2005). Assessing spatial and nonspatial factors for healthcare access: towards 
an integrated approach to defining health professional shortage areas. Health Place. 
11:131–146. 
Weeks WB, Kazis LE, Shen Y, et al. (2004). Differences in Health-Related Quality of Life in 
Rural and Urban Veterans. American Journal of Public Health. 94(10):1762-1767. 
  
41 
 
Fig 2.1 Population density across the counties of PA, OH, KY, and NC. 
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Prov. - Pop. 
Ratio
1
Travel Time -0.115 1
Original 2SFCA 0.351 -0.180 1
Slow 2SFCA 0.510 -0.416 0.753 1
Fast 2SFCA 0.545 -0.522 0.640 0.948 1
Slow - Var. 
Catch. 2SFCA a
0.541 -0.243 0.619 0.835 0.818 1
Fast - Var. 
Catch. 2SFCA b
0.503 -0.485 0.603 0.882 0.909 0.901 1
Cont. - Var. 
Catch. 2SFCA c
0.537 -0.212 0.599 0.790 0.777 0.953 0.836 1
Slow - Var. 
Catch. SPAR
0.541 -0.243 0.619 0.835 0.818 1.000 0.901 0.953 1
Fast - Var. 
Catch. SPAR
0.503 -0.485 0.603 0.882 0.909 0.901 1.000 0.836 0.901 1
Prov. - Pop. 
Ratio
Travel 
Time
Original 
2SFCA
Slow 
2SFCA
Fast 
2SFCA
Slow - Var. 
Catch. 
2SFCA
Fast - Var. 
Catch. 
2SFCA
Cont. - Var. 
Catch. 
2SFCA
Slow - Var. 
Catch. SPAR
Fast - Var. 
Catch. SPAR
c Cont. - Var. Catch. 2SFCA: Both continuous-decay weightings and varying catchment size rules
Table 2.1 Spearman correlations* between 10 spatial access to care measures across PA, OH, KY, and NC
* All correlations significant at the 0.01 level
a Slow - Var. Catch. 2SFCA: Both slow-decay weightings and varying catchment size rules
b Fast - Var. Catch. 2SFCA: Both fast-decay weightings and varying catchment size rules
2SFCA, Two-Step Floating Catchment Area; SPAR , Spatial Access Ratio
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Rural Urban Rural Urban Rural Urban Rural Urban
Provider to Population Ratio
0.0000148 
(0.000073)
0.000154 
(0.000070)
0.000134 
(0.000039)
0.000174 
(0.000084)
0.000158 
(0.000066)
0.000283 
(0.000194)
0.000164 
(0.000093)
0.000164 
(0.000111)
0.000123 
(0.000052)
Travel Time to Closest 
Mammograpy Center (min.)
8.67           
(7.83)
17.93 
(11.58)
6.78      
(6.39)
14.08 
(9.95)
6.81      
(5.85)
16.42 
(11.36)
10.25 
(8.95)
17.21 
(10.81)
10.48 
(7.71)
Origianl 2SFCA
0.000129 
(0.000049)
0.000101 
(0.000037)
0.000115 
(0.000039)
0.000109 
(0.000034)
0.000144 
(0.000040)
0.000197 
(0.000116)
0.000147 
(0.000058)
0.000098 
(0.000041)
0.000120 
(0.000038)
Slow-decay 2SFCA
0.000136 
(0.000058)
0.000105 
(0.000052)
0.000124 
(0.000046)
0.000113 
(0.000047)
0.000150 
(0.000049)
0.000207 
(0.000145)
0.000156 
(0.000066)
0.000108 
(0.000061)
0.000124 
(0.000047)
 Fast-decay 2SFCA
0.000140 
(0.000070)
0.000112 
(0.000077)
0.000128 
(0.000053)
0.000122 
(0.000066)
0.000154 
(0.000060)
0.000221 
(0.000188)
0.000159 
(0.000079)
0.000120 
(0.000090)
0.000127 
(0.000058)
Slow-decay, variable catchment 
2SFCA
0.000049 
(0.000024)
0.000038* 
(0.000018)
0.000038 
(0.000020)
0.000046 
(0.000019)
0.000050 
(0.000014)
0.000078 
(0.000054)
0.000069 
(0.000033)
0.000044 
(0.000023)
0.000054 
(0.000021)
Fast-decay, Variable Catchment 
2SFCA
0.000041 
(0.000023)
0.000023 
(0.000015)
0.000032 
(0.000017)
0.000029 
(0.000015)
0.000047 
(0.000017)
0.000049 
(0.000042)
0.000056 
(0.000035)
0.000028 
(0.000019)
0.000042 
(0.000021)
Continuous-decay, Variable 
Catchment 2SFCA
0.000046 
(0.000024)
0.000036 
(0.000018)
0.000034 
(0.000019)
0.000041 
(0.000018)
0.000043 
(0.000013)
0.000074 
(0000054)
0.000064 
(0.000029)
0.000048 
(0.000025)
0.000058 
(0.000020)
Slow-decay, Variable Catchment 
SPAR
1.00 (0.49)
0.77* 
(0.37)
0.77 (0.41) 0.93 (0.39) 1.03 (0.28) 1.60 (1.11) 1.41 (0.68) 0.89 (0.47) 1.10 (0.42)
Fast-decay, Variable Catchment 
SPAR
1.00 (0.55) 0.57 (0.37) 0.79 (0.41) 0.71 (0.37) 1.15 (0.42) 1.20 (1.03) 1.38 (0.85) 0.68 (0.47) 1.03 (0.52)
* Not siginificant at p < 0.05; all other Rural and Urban comparisons were significant at P < 0.01 .
2SFCA, Two-Step Floating Catchment Area; SPAR , Spatial Access Ratio
Table 2.2 Descriptive statistics of mammography center spatial access scores between rural and urban census block groups of PA, OH, KY, and NC.
Spatial Access Measures All States       
Mean (SD)
Pennsylvania Ohio Kentucky North Carolina
App Non-App App Non-App App Non-App App Non-App
Provider to Population Ratio
0.0000148 
(0.000073)
0.00146 
(0.000048)
0.000125 
(0.000031)
0.000189 
(0.000124)
0.000153 
(0.000043)
0.000244 
(0.00019)
0.000170 
(0.000093)
0.000128* 
(0.000082)
0.000126 
(0.000056)
Travel Time to Closest 
Mammograpy Center (min.)
8.67           
(7.83)
9.77      
(8.68)
5.00      
(4.19)
11.31 
(9.36)
6.39      
(5.20)
16.79 
(11.77)
9.56      
(8.14)
11.98 
(8.17)
10.96 
(8.35)
Origianl 2SFCA
0.000129 
(0.000049)
0.000132 
(0.000037)
0.000097 
(0.000033)
0.000129 
(0.000044)
0.000145 
(0.000039)
0.000202 
(0.000109)
0.000141 
(0.000052)
0.000099 
(0.000032)
0.000122 
(0.000039)
Slow-decay 2SFCA
0.000136 
(0.000058)
0.000138 
(0.000050)
0.000109 
(0.000038)
0.000144 
(0.000073)
0.000149 
(0.000042)
0.000204 
(0.000134)
0.000153 
(0.000064)
0.000109 
(0.000044)
0.000126 
(0.000049)
 Fast-decay 2SFCA
0.000140 
(0.000070)
0.000140 
(0.000061)
0.000115 
(0.000043)
0.000157 
(0.000098)
0.000151 
(0.000049)
0.000208 
(0.000172
0.000159 
(0.000079)
0.000115 
(0.000059)
0.000129 
(0.000062)
Slow-decay, Variable Catchment 
2SFCA
0.000049 
(0.000024)
0.000046 
(0.000021)
0.000029 
(0.000014)
0.000048 
(0.000018)
0.000050 
(0.000013)
0.000079 
(0.000050)
0.000068 
(0.000033)
0.000047 
(0.000018)
0.000055 
(0.000022)
Fast-decay, Variable Catchment 
2SFCA
0.000041 
(0.000023)
0.000035 
(0.000019)
0.000028 
(0.000013)
0.000037 
(0.000021)
0.000048 
(0.000016)
0.000049 
(0.000039)
0.000057 
(0.000036)
0.000032 
(0.000016)
0.000043 
(0.000022)
Continuous-decay, Variable 
Catchment 2SFCA
0.000046 
(0.000024)
0.000043 
(0.000020)
0.000025 
(0.000012)
0.000043* 
(0.000016)
0.000043 
(0.000013)
0.000075 
(0.000049)
0.000063 
(0.000030)
0.000050 
(0.000019)
0.000059 
(0.000021)
Slow-decay, Variable Catchment 
SPAR
1.00 (0.49) 0.95 (0.42) 0.60 (0.29) 0.98 (0.37) 1.03 (0.26) 1.62 (1.02) 1.39 (0.68) 0.95 (0.36) 1.12 (0.44)
Fast-decay, Variable Catchment 
SPAR
1.00 (0.55) 0.87 (0.47) 0.69 (0.33) 0.91 (0.52 1.17 (0.39) 1.21 (0.95) 1.39 (0.87) 0.78 (0.40) 1.04 (0.54)
* Not siginificant at p < 0.05; all other Appalachia and Non-Appalachia comparisons were significant at P < 0.01 .
2SFCA, Two-Step Floating Catchment Area; SPAR , Spatial Access Ratio
Table 2.3 Descriptive statistics of mammography center spatial access scores between Appalachia and non-Appalachia census block groups of PA, 
OH, KY, and NC.
Spatial Access Measures All States       
Mean (SD)
Pennsylvania Ohio Kentucky North Carolina
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CHAPTER 3 
Spatial Access to Primary Care Providers in Appalachia: Evaluating Current Methodology 
 
3.1 Abstract 
Purpose 
The goal of this research was to examine spatial access to primary care physicians in Appalachia 
using both traditional access measures and the two-step floating catchment area (2SFCA) 
method. Spatial Access to care was compared between urban and rural regions of Appalachia.  
Methods 
The study region included Appalachia counties of Pennsylvania, Ohio, Kentucky, and North 
Carolina. Primary care physicians during 2008 and total census block group populations were 
geocoded into GIS software. Ratios of county physicians to population, driving time to nearest 
physician, and various 2SFCA approaches were compared. 
Results 
Urban areas of the study region had shorter travel times to their closest primary care physician. 
Provider to population ratios produced results that varied widely from one county to another due 
to strict geographic boundaries. The 2SFCA method produced varied results depending on the 
chosen distance decay weight and variable catchment size technique. 2SFCA scores showed 
greater access to care in urban areas of PA, OH, and NC.  
Conclusion 
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The different parameters of the 2SFCA method—distance decay weight and variable catchment 
size—have a large impact on the resulting spatial access to primary care scores. We recommend 
using a relative 2SFCA approach, the spatial access ratio (SPAR) method, when detailed patient 
travel data are unavailable. The 2SFCA method shows promise for measuring access to care in 
Appalachia, but more research on patient travel preferences is needed to inform implementation. 
 
3.2 Introduction 
 Appalachia is a mountainous region that spans the northern portions of Mississippi and 
Alabama in the south and reaches into the southern portion of New York at its northern end. 
Appalachia is largely rural, with 42% of its population classified as rural compared to the 
national average of 20% (Appalachia Regional Commission, 2014). Socioeconomically, the 
region has a lower per capita income and a higher poverty rate than the national average (Pollard 
& Jacobson, 2014). Access to adequate healthcare is an ongoing concern in Appalachia, largely 
due to the mountainous terrain, rural population distribution, and socioeconomic disparities 
(Lengerich et al., 2005). 
 Access to primary care services is especially important given primary care providers’ role 
as a gateway to health systems (Starfield et al., 2005). In Appalachia, regular primary care 
encounters have been shown to increase early cancer detection and reduce mortality (Camacho et 
al., 2014). In Appalachia Ohio, children with irregular primary care visits had poorer general 
health outcomes, and the parents of those children reported that lack of access to primary care 
prevented regular contact (Smith & Holloman, 2011). Regular, quality primary care encounters 
can also counteract the negative effects that economic disparities have on heath (Shi, 2012), a 
particularly important outcome given Appalachia’s generally reduced economic status. 
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 Accurately measuring access to primary care is important in Appalachia. Spatial access is 
one component of access to care, distinct from non-spatial factors such as insurance status or 
level of education (Wang & Luo, 2005). One traditional measure of spatial access is a county 
provider to population ratio. The technique is self-explanatory, deriving a ratio of practicing 
healthcare providers to the total county population, often drawn from U.S. Census data. The U.S. 
Department of Health and Human Services (DHHS) relies on this technique when designating 
Health Professional Shortage Areas (HPSA; DHHS, 2010). Another common strategy for 
measuring spatial access to care is to use geographic information systems (GIS) software to 
calculate the shortest travel time between population points and healthcare providers. Instead of 
generalizing across an entire geographic area, shortest travel time measures focus more 
specifically on a smaller population unit, often census tracts, census block groups, or individual 
patients (Wang, 2012). 
 There are noted limitations to these standard measures of spatial access to care 
(Guagliardo, 2004). The geographic boundaries used in provider to population ratios are not 
representative of typical healthcare use. Patients often cross county boundaries, and providers 
within a county boundary may not actually be accessible, especially in large, rural counties 
(Wang, 2012). Travel time calculations overcome the latter problem of travel cost between 
patients and providers. However, travel time measures do not account for the supply and demand 
factors that impact healthcare (Luo & Wang, 2003). 
 A more recent method for measuring spatial access to care is the two step floating 
catchment area (2SFCA) method, which was designed to overcome some of the limitations of 
provider to population ratios and travel time (Luo & Wang, 2003; Wang & Luo, 2005). The 
2SFCA method begins by setting a catchment area (usually 30 or 60 minutes) around each 
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healthcare provider and identifying all the populations within that provider’s catchment. A 
provider to population ratio is then calculated for each provider’s catchment. In step two, each 
population becomes the center of a catchment, and the step one ratios associated with each 
provider in that population’s catchment are summed. 
 Several additional parameters have been added to the original 2SFCA framework (Luo & 
Qi, 2009; McGrail & Humphreys, 2009). Catchments at both steps can be further refined by 
adding a distance decay function, where distinct zones (e.g., 0-10 min., 10-20 min, 20-30 min.) 
each receive unique weights (Luo & Qi, 2009). Instead of separate zones, a continuous function 
can also be applied to travel distance within catchments (McGrail & Humphreys, 2009). Another 
improvement added to the original 2SFCA method is the technique of varying catchment sizes at 
both step one and two. This approach attempts to capture the fact that different healthcare 
providers serve patients at varying geographic distances, such as in rural compared to urban 
settings (McGrail, 2012). Thus, catchment sizes should not remain uniform across all providers 
and populations, and can be limited by capping the number of providers that a population can 
access, for example (McGrail & Humphreys, 2009). Lastly, owing to the uncertainty in how to 
weight travel within catchments, or how exactly to vary catchments, a relative approach called 
the Spatial Access Ratio (SPAR) was created (Wan et al., 2012). This technique divides a 
population’s 2SFCA score by the mean 2SFCA score of all populations, which researchers 
demonstrated minimizes the differences in 2SFCA scores resulting from using different decay 
weights (Wan et al., 2012). 
 Despite its theoretical advantages and its empirical validity in predicting clinical 
outcomes (Dai, 2010; Lian et al., 2012), the 2SFCA method has never been used to study access 
to primary care in Appalachia. The primary focus of this study was to examine spatial access to 
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primary care in Appalachia using both the traditional measures of provider to population ratios 
and closest travel time, as well as the 2SFCA method and its various parameters. Within 
Appalachia, results were compared between urban and rural areas.  
 
3.3 Study Area and Data 
  The study examined the Appalachia regions of Pennsylvania, Ohio, Kentucky, and North 
Carolina. Appalachia counties were determined using the Appalachia Regional Commission’s 
(ARC) county designations. Primary care physicians were derived from the 2008 American 
Medical Association (AMA) Physician Masterfile, using specialties of Family Practice, General 
Practice, Internal Medicine, and General Pediatrics (Camacho et al., 2014). Office addresses at 
the street level were available for 8,039 of the 9,483 physicians in the study area. The population 
weighted centroid of the physician’s office census tract was used for the remaining 1,444 
physicians. Primary care physicians from neighboring states and neighboring in-state, non-
Appalachia areas were not included, creating possible edge effects. 
 The 2010 U.S. Census was used to derive population data at the census block group level. 
Block groups are ideally comprised of 1,500 people, with a range from 600 to 3,000. The 
population weighted centroid (U.S. Census Bureau, 2014) of each block group was used as the 
geographic reference, similar to previous research (Luo & Wang, 2003). Many previous studies 
measuring spatial access to care used the larger geographic areas of zip codes (Dai, 2010) or 
census tracts (Wan et al., 2012), which provide less geographic specificity than the smaller 
census block groups. We did include neighboring block groups within one hour travel time of 
our Appalachia study area. There were 8,721 populated block groups in Appalachia regions of 
the four states, resulting in a total population of 10,717,421 people.  
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 Within Appalachia, populations were also dichotomized as urban and rural. Designation 
occurs at the census block level by assigning RUCU codes 7-10 as rural and RUCU codes 1-6 as 
urban (Weeks et al., 2004). Codes 1-6 also include suburban areas, but these areas were grouped 
as urban for ease of interpretation (Weeks et al., 2004). Descriptive statistics and t-tests were 
used to examine the differences between rural and urban regions. 
 
3.4 Methodology 
Provider to population ratios 
 Primary care provider to population ratios were calculated at the county level. The total 
primary care providers in each county were divided by that counties total population. Although 
primary care data was current as of 2008, and population data was from the 2010 Census, the 
2010 Census offered a closer approximation than 2000 Census data. 
Travel Time 
 Primary care providers and census block groups were geocoded into ArcGIS (Version 
10.1, ESRI Inc., Redlands, CA). The Origin-Destination (OD) cost matrix function of the 
ArcGIS Network Analyst extension was used to determine travel times between the population 
weighted centroid of each block group and the closest primary care provider. Similar to previous 
research (Wang, 2012), and corresponding with the maximum time used in the 2SFCA method, a 
maximum travel time of 60 minutes was set.  
Two-step floating catchment area  
 The 2SFCA method begins by identifying all populations (k) within a service provider’s 
(j) maximum catchment (do), which we set as 60 minutes driving time. The rural characteristics 
of Appalachia necessitated the 60 minute maximum time, rather than a 30 minute maximum 
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(McGrail & Humphreys, 2009). After identifying all populations, a population to provider ratio 
(Rj) is then computed using the total service providers (Sj) and the total population (Pk) within 
catchment j: 
 Step 1: Rj = Sj  / ∑k ∈	{djk < do} Pk 
 The next step of the 2SFCA method searches for all service providers (j) within the 
maximum travel time (do) of a population location (i). The sum of all the eligible service 
providers’ step 1 ratios (Rj) is then calculated, resulting in that population location’s access score 
(Ai): 
 Step 2: Ai = ∑ j ∈	{dij < do} Rj 
 Several additional versions of the 2SFCA were also considered. A distance decay 
function was added across four time zones within catchments, corresponding to travel times of 0-
10 minutes, 11-20 minutes, 21-30 minutes, and 31-60 minutes (Luo & Qi, 2009). A different 
weight was applied at each zone, reflecting the travel cost associated with increasing time. Two 
weighting schemes were compared (McGrail, 2012; Wan et al., 2010): 
 Fast-decay weights (w) = 1, 0.60, 0.25, 0.05 
 Slow-decay weights (w) = 1, 0.80, 0.55, 0.15 
Weights are applied at each step and correspond to the 0-10, 11-20, 21-30, and 31-60 
minute time zones within each catchment. Thus, during step one all populations (k) are reduced 
by the above weights, depending on the travel time to that catchment’s provider (j). In step two, 
each provider ratio (Rj) is reduced by its corresponding weight. This yields the following update 
step one and two equations: 
 Step 1: Rj = Sj / ∑k ∈	{djk < do} Pk w 
 Step 2: Ai = ∑ j ∈	{dij < do} Rj w 
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Another 2SFCA version was compared that included both distance decay weights and 
varying catchment sizes. The varying catchment method used a different technique for step one 
and two of the 2SFCA (McGrail, 2012). Local population distributions were used in step one to 
decide whether or not the distance decay weights were applied, thereby expanding or contracting 
the provider’s catchment. Populations within the first 10 minutes of a provider had no decay 
weight. If a provider was one of the closest 25 providers to a population it was assumed that 
population would travel because it had fewer choices, thus no decay weight was applied to that 
population. Also, no decay weight was applied if the provider’s town had a population of 5,000 
or greater and the population’s town had a total population of less than half the provider’s. This 
scenario attempts to capture smaller towns that will travel to access providers in larger nearby 
communities (McGrail & Humphreys, 2009b). Primary care providers and block groups were 
linked to their closest Census Designated Place (CDP) to estimate the population of their closest 
towns. The Census Bureau describes CDPs as representative of a settled concentration of 
populations in a city, town, village, or borough (U.S. Census Bureau, 2014b).  
In determining step two catchments of the 2SFCA, block groups were only allowed to 
access their closest 100 primary care providers, simulating the point at which additional 
providers are unlikely to be utilized. The first 100 providers, however, would have distance 
decay weights applied as usual. For the distance decay and variable catchment size approach, a 
continuous distance decay weighting scheme was also applied to contrast with the fast and slow 
weighting scheme (McGrail & Humphreys, 2009). Thus, the same rules as above were applied, 
but when a decay weight was to be used for travel times (d) between 10 and 60 minutes, the 
following weight (w) was applied: 
 Continuous-decay weight (w) = ((60-d) / (60-10)) ^ 1.5 
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 The last 2SFCA method evaluated in our study region was the spatial access ratio 
(SPAR) score (Wan et al., 2012). Each of the other 2SFCA methods makes assumptions about 
patient healthcare behavior when assigning certain weights or capping a catchment at a certain 
number of providers. SPAR was created to minimize the subjectivity when choosing distance 
decay weights and varying catchment sizes. A SPAR score is given by dividing a census block 
group’s 2SFCA score by the mean 2SFCA score of all the block groups in the entire study area 
(Wan et al., 2012). 
 A total of 10 spatial access scores were applied to each census block group in the 
Appalachia regions in PA, OH, KY, and NC: 1) Ratio of county primary care providers to total 
county population; 2) Travel time to closest primary care provider; 3) Original 2SFCA score; 4) 
Slow-decay 2SFCA score; 5) Fast-decay 2SFCA score; 6) Slow-decay and variable catchment 
2SFCA score; 7) Fast-decay and variable catchment 2SFCA score; 8) Continuous-decay and 
variable catchment 2SFCA score; 9) Slow-decay and variable catchment SPAR score; 10) Fast-
decay and variable catchment SPAR score.  
 
3.5 Results 
 The greater Pittsburgh area had the highest population density of our four state 
Appalachia region (Fig. 3.1). The Youngstown area along the PA-OH border, the Erie area in 
northwest PA, and the Greensboro and Ashland areas in NC all also had among the most 
populated counties in our study region. North-central PA and eastern KY were the least 
populated areas.  
 All spearman nonparametric correlations were significant between the 10 spatial access 
measures, except for the correlation between travel time and continuous-decay, variable 
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catchment scores (Table 3.1). For reference, the provider to population ratios, 2SFCA scores, and 
SPAR scores are all similar in that increasing values signify greater spatial access. Travel time is 
opposite, where lower times indicate greater spatial access, which is why travel time was 
negatively correlated with each of the other measures. There was a marked difference between 
the 2SFCA measures that included a variable catchment size function and those that did not. For 
example, provider to population ratios and travel time were more strongly correlated with the 
original, slow, and fast-decay 2SFCA scores (0.426 ≤ rho ≤ 0.765) than with the slow, fast, and 
continuous-decay 2SFCA scores that also had varying catchment sizes (0.017 ≤ rho ≤ 0.34). The 
correlations within these groups were strong—the original, slow, and fast-decay 2SFCA scores 
between 0.719 and 0.970 and the slow, fast, and continuous-decay 2SFCA scores with varying 
catchment sizes between 0.805 and 0.972—but the correlation between groups was not as strong 
(-0.174 ≤ rho ≤ 0.463). As expected, the correlations were identical between the slow and fast-
decay 2SFCA scores with varying catchment sizes and their corresponding SPAR scores. 
 Several of the areas with the greatest population density also had the highest ratio of 
primary care physicians to county population, including the Pittsburgh, Ashland, and Greensboro 
areas (Fig. 3.2a). There were also rural regions with higher ratios, such as in eastern KY, 
northeastern PA, and eastern OH. Many of the counties with ratios in the highest quintile were 
bordering counties with ratios in the lowest quintile, demonstrating the impact that county 
boundary lines can have when using provider to population ratios. 
 The majority of census block groups were within a 10 minute drive time of their closest 
primary care physician (Fig. 3.2b). The regions with the largest travel times were generally those 
with the lowest population density, as shown in Figure 3.1. Block groups with the largest travel 
times were found throughout north central PA, the entire Appalachia region of KY, and western 
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NC. It is difficult to interpret the presence of the largest travel times (i.e., the group of 41-60 
minutes) in the far eastern part of our KY and NC regions because those areas border regions 
where we did not have access to primary care data. Thus, it is possible that those region’s true 
time to their closest primary care physician is less than shown. 
 The census block groups with the highest original 2SFCA scores were located primarily 
in the Pittsburgh area (Fig. 3.3a). After adding distance decay weights, 2SFCA scores were 
reduced in the suburban areas surrounding Pittsburg but increased in several other population 
centers of our study region, including near the Greensboro, Ashland, and Youngstown areas (Fig. 
3.3b, 3.3c). Overall, decay weights appear to have dispersed scores, rather than concentrating 
them across one large, adjoining area, as with the original 2SFCA scores.  This was especially 
true for the fast-decay weighting scheme (Fig. 3.3c). Adding variable catchment sizes with decay 
weights drastically altered the distribution of spatial access 2SFCA scores (Fig. 3.3d, 3.3e, 3.3f).  
 Across each measure that varied catchment sizes—slow, fast, and continuous decay 
weightings—the Pittsburg area went from having among the highest scores to either mediocre or 
poor scores. For reference, there were roughly 2,900 primary care providers within a 1 hour drive 
of the urban core of Pittsburgh. When variable catchments were introduced, those urban 
populations had their possible number of primary care services capped at 100, resulting in the 
significant drop in scores. The block groups that saw comparatively higher scores, conversely, 
were largely in the smaller town areas of central PA, southern OH, eastern KY, and western NC. 
In the southern OH town of Portsmouth, for example, there were approximately 190 primary care 
physicians within a 1 hour drive. Consequently, capping the number of providers had a much 
smaller effect than in Pittsburg. Yet, because the population density is lower (approximately 
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20,000 compared to 300,000 in Pittsburgh), the 2SFCA step one ratio scores for Portsmouth and 
similar small towns were higher, resulting in higher overall 2SFCA scores. 
 The difference between slow and fast-decay variable catchment 2SFCA scores was 
similar to the difference when only decay weights and no variable catchment function were used. 
Fast-decay weights resulted in tighter groupings of higher access block groups at population 
centers, rather than the slow-decay weight scenario of high access block groups sprawled across 
population centers and surrounding suburbs (Fig. 3.3d, 3.3e). When a continuous decay 
weighting scheme was used with varying catchment sizes, the result was nearly identical to the 
slow-decay, variable catchment size approach (Fig. 3.3d, 3.3f). The slow and fast-decay, variable 
catchment SPAR scores demonstrated the same differences as their corresponding 2SFCA scores 
(Fig. 3.3g, 3.3h). Figure 3.4 compares the change in actual 2SFCA scores across rural and urban 
areas when using slow and fast decay weights. Urban areas were responsible for the highest 
scores, regardless of the 2SFCA iteration used. After using only the distance decay technique, 
scores generally did not uniformly increase or decrease according to the weight used (Fig. 3.4a, 
3.4b). The exception was for the highest scoring urban block groups, where the fast-decay 
weights universally increased scores (Fig. 3.4b). After adding variable catchment sizes and decay 
weights, however, a clear pattern emerged where fast-decay weights decreased scores for most 
block groups (Fig. 3.4c, 3.4d). The results when using the decay-weighted and variable 
catchment SPAR scores were mixed (Fig. 3.4e, 3.4f). For block groups classified as urban (7,266 
of the 8,721 block groups were classified as urban), the SPAR technique achieved it intended 
effect of preventing any noticeable increase or decrease in scores based on decay weighting (Fig. 
3.4f). The SPAR technique was less effective for rural block groups, where fast-decay weights 
uniformly decreased scores (Fig. 3.4e). 
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 Table 3.2 compares the rural and urban mean spatial access scores across each state of the 
study region. Urban block groups in PA, OH, and NC had higher provider to population ratios, 
while higher ratios came from rural block groups in KY. Travel time to the closest primary care 
provider was lower for urban block groups across each state. The mean scores for the entire 
region demonstrate that the addition of a variable catchment size decreased scores considerably, 
regardless of the decay weighting scheme chosen. In PA and NC, urban areas had larger 2SFCA 
scores except for the slow and continuous decay, variable catchment scores, where rural areas 
performed better. Ohio’s urban block groups performed even better, scoring higher than rural 
block groups across each 2SFCA iteration. Scores in KY were largely reversed, where rural 
block groups performed better across each 2SFCA method except the fast-decay and variable 
catchment size approach. 
 
3.6 Discussion 
 This research presented the first comparison in Appalachia of the most recently 
developed spatial access to care methods. Based on nonparametric correlations, the 2SFCA 
measures that included variable catchment sizes appeared distinct from the measures of provider 
to population ratios, closest travel time, and the 2SFCA method with and without decay weights. 
When comparing provider to population ratios across the study region, the most populated urban 
areas (e.g., Pittsburgh, Greensboro) had the highest ratios. Several rural areas had high ratios as 
well, but abrupt county boundaries made interpretation difficult because several adjacent 
counties had ratios in the highest and lowest quintile groups. The majority of census block 
groups were within 10 minutes of their closest primary care provider. Rural block groups in each 
state faced longer travel times than urban block groups. The urban-rural travel time was most 
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similar in KY, where times were higher than average for both groups. Urban block groups in 
KY, for instance, had longer travel times (9.54 min.) than the rural block groups of PA (7.50 
min.) and OH (8.26 min.). Mapping the different 2SFCA scores across the study region revealed 
differences—similar to the correlation analysis—between the 2SFCA approaches that included 
variable catchment sizes and those that did not. The variable catchment size method resulted in 
several urban areas, including the greater Pittsburgh area, having among the worst access scores. 
When catchment sizes remained static, and corresponding populations of these urban areas had 
no cap on the number of physicians they could access, these same urban areas had among the 
highest 2SFCA access scores. 
 Traditionally, when the original 2SFCA method was applied to primary care physicians, 
urban areas often received the highest scores (Luo & Wang, 2003; Wang & Luo, 2005). This 
also proved true with our results in Appalachia. Pittsburgh was the largest urban area in the study 
region, and it had the highest original 2SFCA scores. When distance-decay weights were added, 
Pittsburgh’s core maintained comparatively high access scores, but the surrounding suburbs were 
reduced to more mediocre scores. Those surrounding populations, especially those with a 30-60 
minute drive from the center of Pittsburgh, were no longer able to count the abundance of central 
Pittsburgh physicians as accessible. This pattern matches the intended effect behind distance-
decay functions, which was partly to limit accessibility at the boundaries of physician catchments 
(Luo & Qi, 2009). After adding distance-decay weights, the same effect occurred across other 
areas where original 2SFCA scores were high across a contiguous area, such as near 
Youngstown, OH and along the Williamsport to Scranton corridor in central and northeastern 
PA.  
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 Adding variable catchment sizes to the slow and fast decay 2SFCA approach produced 
dramatic differences in the distribution of access scores. Pittsburgh’s scores ranked among the 
lowest of the study region. Smaller rural towns in eastern KY, southern OH, western NC, and 
central PA—who without variable catchments only had mediocre scores—had among the highest 
scores in the study region. The variable catchment approach we used capped the number of 
physicians a population could access at 100 (McGrail & Humphreys, 2009). Most towns of 
15,000 people or greater were within a one hour drive of 100 primary care physicians. But, the 
population demand on those physicians was less in rural areas, resulting in the increased scores 
relative to the major urban area of Pittsburgh. 
 Although theoretically similar, the distance-decay weights chosen in this study did impact 
the distribution of the highest and lowest access scores. Fast decay weights, when used 
independently and when used in conjunction with variable catchment sizes, resulted in a more 
concentrated pattern of high scores in town centers compared to slow and continuous weighting 
schemes. The SPAR method was created in part to mitigate those differences (Wan et al., 2012). 
For the 83% of census block groups classified as urban (this included suburban areas as well, for 
ease of interpretation), changing from the slow decay, variable catchment method to the fast 
decay, variable catchment method did not result in any uniform increase or decrease in mean 
access scores. For rural block groups, however, SPAR did not have its intended effect as nearly 
all scores decreased when changing from the slow decay, variable catchment method to the fast 
decay, variable catchment method. Wan et al. (2012) did not include variable catchment sizes in 
their SPAR models, and it appears that the relative smoothing effect of SPAR was not enough to 
counteract the effect of the fast decay, variable catchment approach of rural block groups’ scores. 
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Indeed, when only including decay weights and not variable catchment sizes, the SPAR 
technique did stabilize slow and fast decay scores in rural areas (data not shown).  
 This research had several strengths. It represents the first application of the 2SFCA 
method to study access to primary care in Appalachia. Public health research in Appalachia is 
increasingly utilizing GIS techniques (Anderson et al., 2014), which makes it imperative that the 
most current spatial access methods are evaluated. A methodological strength in this study was 
the increased geographic specificity as a result of using census block groups as the geographic 
population area, rather than the larger census tracts or zip codes that other research applying the 
2SFCA method has employed (Diad, 2010; Lian et al., 2012; Wan et al., 2012). Another 
methodological strength was the inclusion of variable catchment sizes, which allowed the 
comparison between identical distance decay 2SFCA measures either with or without varying 
catchments, instead of only evaluating decay weights (Mao & Nekorchuk, 2013; Tao et al., 
2014).   
 There were also several limitations to this research. From a methodological perspective, 
not including neighboring primary care physicians likely created edge effects along the border of 
our study region. Another limitation, common in much research examining potential spatial 
access, was the lack of actual patient healthcare utilization behaviors. The application of 
distance-decay weights and variable catchment sizes is theoretically sound. Grounding distance 
decay and variable catchment functions in empirical data is more difficult. The specific 
parameters of these 2SFCA iterations need to be evaluated against patient healthcare behavior, 
preferably at the local level of a study region.  
 In summary, we recommend the SPAR technique for use when patients’ healthcare 
travelling data is unavailable. Including variable catchment sizes is a theoretical improvement to 
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the 2SFCA method, but choosing optimal parameters to vary catchment sizes by is difficult. We 
recommend that researchers compare several parameters (e.g., capping the number of physicians 
a population can access at higher and lower values than the standard approach of 100) and 
contrast the effects with 2SFCA methods that only employ distance decay weights. 
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Figure 3.1 Population densities from the 2010 U.S. Census in Appalachia counties of PA, OH, KY, and NC. 
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Prov. - Pop. 
Ratio
1
Travel Time -0.381 1
Original 2SFCA 0.564 -0.426 1
Slow 2SFCA 0.765 -0.566 0.833 1
Fast 2SFCA 0.760 -0.626 0.719 0.970 1
Slow - Var. 
Catch. 2SFCA a
-0.046 -0.045 -0.115 0.056 0.124 1
Fast - Var. 
Catch. 2SFCA b
0.198 -0.342 0.150 0.374 0.463 0.874 1
Cont. - Var. 
Catch. 2SFCA c
-0.117 0.017+ -0.174 -0.043 0.023 0.972 0.805 1
Slow - Var. 
Catch. SPAR
-0.046 -0.045 -0.115 0.056 0.124 1.000 0.874 0.972 1
Fast - Var. 
Catch. SPAR
0.198 -0.342 0.150 0.374 0.463 0.874 1.000 0.805 0.874 1
Prov. - Pop. 
Ratio
Travel 
Time
Original 
2SFCA
Slow 
2SFCA
Fast 
2SFCA
Slow - Var. 
Catch. 
2SFCA
Fast - Var. 
Catch. 
2SFCA
Cont. - Var. 
Catch. 
2SFCA
Slow - Var. 
Catch. SPAR
Fast - Var. 
Catch. SPAR
+ Not significant
c Cont. - Var. Catch. 2SFCA: Both continuous-decay weightings and varying catchment size rules
Table 3.1 Spearman correlations* between 10 spatial access to prmiary care measures across Appalachia PA, OH, KY, and NC
* All correlations significant at the 0.05 level, unless otherwise noted
a Slow - Var. Catch. 2SFCA: Both slow-decay weightings and varying catchment size rules
b Fast - Var. Catch. 2SFCA: Both fast-decay weightings and varying catchment size rules
2SFCA, Two-Step Floating Catchment Area; SPAR , Spatial Access Ratio
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Rural Urban Rural Urban Rural Urban Rural Urban
Provider to Population Ratio
0.000880 
(0.000542)
0.000710 
(0.000347)
0.001031 
(0.000637)
0.000481 
(0.000209)
0.000708 
(0.000301)
0.000636 
(0.000304)
0.000553 
(0.000257)
0.000747 
(0.000307)
0.000970 
(0.000467)
Travel Time to Closest 
Mammograpy Center (min.)
5.81           
(6.31)
7.50    
(6.92)
4.03      
(4.77)
8.26   
(7.29)
5.88      
(5.98)
11.89 
(8.81)
9.54   
(7.79)
10.62   
(7.64)
6.122 
(5.79)
Origianl 2SFCA
0.000706 
(0.000382)
0.000507 
(0.000238)
0.000936 
(0.000351)
0.000321 
(0.000195)
0.000465 
(0.000272)
0.000470 
(0.000232)
0.000410 
(0.000174)
0.000370 
(0.000160)
0.000583 
(0.000265)
Slow-decay 2SFCA
0.000768 
(0.000490)
0.000477 
(0.000245)
0.001002 
(0.000518)
0.000323 
(0.000161)
0.000529 
(0.000320)
0.000501 
(0.000306)
0.000435 
(0.000223)
0.000416 
(0.000190)
0.000724 
(0.000378)
 Fast-decay 2SFCA
0.000804 
(0.000573)
0.000472 
(0.000260)
0.001032 
(0.000629)
0.000342 
(0.000186)
0.000579 
(0.000389)
0.000528 
(0.000398)
0.000451 
(0.000265)
0.000455 
(0.000254)
0.000807 
(0.000480)
Slow-decay, variable catchment 
2SFCA
0.000134 
(0.000078)
0.000154 
(0.000075)
0.000122 
(0.000074)
0.000114 
(0.000056)
0.000125 
(0.000055)
0.000191 
(0.000115)
0.000177 
(0.000083)
0.000183 
(0.000107)
0.000136 
(0.000069)
Fast-decay, Variable Catchment 
2SFCA
0.000116 
(0.000071)
0.000107 
(0.000062)
0.000116 
(0.000072)
0.000076 
(0.000045)
0.000108 
(0.000054)
0.000119 
(0.000090)
0.000132 
(0.000082)
0.000133* 
(0.000095)
0.000126 
(0.000069)
Continuous-decay, Variable 
Catchment 2SFCA
0.000147 
(0.000086)
0.000177 
(0.000082)
0.000130 
(0.000080)
0.000134* 
(0.000068)
0.000142 
(0.000061)
0.000206 
(0000125)
0.000195 
(0.000092)
0.000212 
(0.000123)
0.000149 
(0.000079)
Slow-decay, Variable Catchment 
SPAR
1.00 (0.58) 1.15 (0.56) 0.91 (0.55) 0.85 (0.42) 0.94 (0.41) 1.43 (0.86) 1.32 (0.62) 1.39 (0.79) 1.01 (0.52)
Fast-decay, Variable Catchment 
SPAR
1.00 (0.61) 0.92 (0.53) 1.00 (0.62) 0.66 (0.39) 0.93 (0.47) 1.03 (0.77) 1.14 (0.71) 1.14* (0.82) 1.08 (0.59)
* Not siginificant at P < 0.05; all other Rural and Urban comparisons were significant at P < 0.05 .
2SFCA, Two-Step Floating Catchment Area; SPAR , Spatial Access Ratio
Table 3.2. Descriptive statistics of primary care spatial access scores between rural and urban census block groups of Applachia PA, OH, KY, and NC.
Spatial Access Measures All States       
Mean (SD)
Pennsylvania Ohio Kentucky North Carolina
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CHAPTER 4 
Predicting Late-Stage Breast Cancer Diagnosis and Receipt of Adjuvant Therapy: 
Applying Current Spatial Access to Care Methods in Appalachia 
 
4.1 Abstract 
Purpose 
The two-step floating catchment area (2SFCA) method of measuring access to care has never 
been used to study cancer disparities in Appalachia, despite its improvements over traditional 
measures of access to care. We examine the impact of access to mammography centers and 
primary care on late stage breast cancer diagnosis and receipt of adjuvant hormonal therapy.  
Methods 
Cancer registries from Pennsylvania, Ohio, Kentucky, and North Carolina were linked with 
Medicare data to identify the stage of breast cancer diagnosis for Appalachia women diagnosed 
between 2006-2008. Women eligible for adjuvant therapy included those with stage I, II, or III 
diagnosis; mastectomy or breast conserving surgery; and hormone-receptor positive breast 
cancers. Geographically weighted regression (GWR) was used to explore non-stationarity in the 
demographic and spatial access predictor variables. 
Results 
Over 21% of 15,299 women diagnosed with breast cancer received a late-stage (stages III-IV) 
diagnosis. Predictors included age at diagnosis (odds ratio [OR],  0.86; P < 0.001), insurance 
status (OR, 1.32; P < 0.001), county primary care to population ratio (OR, 0.95; P < 0.001), and 
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primary care 2SFCA score (OR, 0.96; P = 0.006). Only 46.9% of eligible women received 
adjuvant hormonal therapy, and significant predictors included comorbidity status (OR, 1.18; P = 
0.047), county economic status (OR, 1.32; P = 0.006), and mammography center 2SFCA scores 
(OR, 1.12; P = 0.021).  
Conclusion 
The 2SFCA method offered the greatest predictive validity of the access measures. Rates of late 
stage breast cancer diagnosis and adjuvant hormonal therapy are substandard in Appalachia. 
 
4.2 Introduction 
 The Appalachia region of the United States has reduced health outcomes and treatment 
patterns across a number of diseases, including breast cancer (Blackley et al., 2012; Reiter et al., 
2013; Sergeev, 2013). Because many areas of Appalachia have lower socioeconomic status 
(Pollard & Jacobson, 2012) and occupy rural, mountainous terrain, reduced access to care is 
often implicated in the region’s cancer disparities (Paskett et al., 2011). 
 Spatial access to care is traditionally measured using either provider to population ratios 
or by computing the travel time between patient and provider (Wang, 2012). Both methods have 
limitations, however. Provider to population ratios use fixed geographic boundaries (e.g., 
counties) that do not reflect actual patient behaviors, while travel time fails to account for supply 
and demand factors (Luo & Wang 2003). More recently, the two-step floating catchment area 
(2SFCA) method was developed to overcome these limitations (Wang & Luo, 2005). Despite its 
improvement over traditional measures of spatial access to care, the 2SFCA method has never 
been used to study cancer outcomes or treatment patterns in Appalachia. 
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 We recently evaluated the impact of different 2SFCA parameter options when measuring 
access to mammography centers (chapter 2) and primary care physicians (chapter 3) in 
Appalachia. Here, we used a linked central cancer registry and Medicare dataset across four 
Appalachian states to evaluate the relationship between spatial access to care and two important 
clinical indicators for breast cancer—late stage diagnosis and receipt of adjuvant hormonal 
therapy. Late stage breast cancer diagnosis leads to fewer treatment options and increased 
mortality (Henry et al., 2011) and is more prevalent in lower socioeconomic, rural, and black 
populations (Amey et al., 1997; Clegg et al., 2009; Lantz et al., 2006). Adjuvant hormonal 
therapy is recommended for hormone receptor positive patients after either breast conserving 
surgery or mastectomy (Howell et al., 2005; Winer et al., 2005). Lower socioeconomic status is 
also associated with reduced rates of adjuvant hormonal therapy (Wu et al., 2012). 
 First, we evaluated the predictive ability of the 2SFCA method compared to traditional 
spatial access approaches. We then used geographically weighted regression (GWR) to examine 
whether the influence of demographic or spatial access predictor variables differed throughout 
the study region.   
 
4.3 Methods 
 This research was approved by the institutional review board at the University of 
Michigan. 
STUDY POPULATION 
 We used PA, OH, KY, and NC Central Cancer Registry (CCR) datasets to identify 
15,299 women diagnosed with breast cancer between 2006 and 2008 who lived in Appalachia 
counties, defined by the Appalachia Regional Commission (ARC). To examine receipt of 
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hormonal therapy, CCR datasets were linked with Medicare claims to further limit the sample to 
patients with Medicare Part D enrollment; diagnosis during year 2007; stage I, II, or III diagnosis 
(Johnson & Ademo, 2007); confirmed mastectomy or breast conserving surgery; and hormone-
receptor positive breast cancers; resulting in 834 women eligible for adjuvant hormonal therapy 
(EBCTCG, 2005). The methods used to link CCR and Medicare datasets have been previously 
described (Anderson et al., 2005). 
DEFINITION OF VARIABLES 
 Dependent Variables. Breast cancer stage at diagnosis and receipt of adjuvant hormonal 
therapy were the two dependent variables. Similar to previous research (Markossian & Hines, 
2012), early stage diagnosis was defined as stages 0, I, or II, while late stage was defined as 
stages III and IV. Patients with prescription codes for tamoxifen, anastrozole, letrozole, or 
exemestane were defined as having received adjuvant hormonal therapy (Howell et al., 2005). 
 Spatial Access Measures. Three spatial access methods were evaluated: 1) county 
provider to population ratios, 2) travel time to closest provider, and 3) the 2SFCA method.  
 Provider to population ratios were calculated for primary care physicians and 
mammography centers. The American Medical Association (AMA) Physician Masterfile from 
2008 was used to identify primary care physicians, which we defined as having specialties of 
Family Practice, General Practice, Internal Medicine, or General Pediatrics (Camacho et al., 
2014). The number of primary care physicians in each county was divided by that county’s 
population, using counties and populations from the 2010 Census, to yield a ratio for each 
county. All 2008 U.S. Food and Drug Administration (FDA) accredited mammography centers 
in Appalachia counties of the study region were identified. The number of mammography 
centers in each county was divided by that counties population of women age 45 and older. 
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Although 2008 guidelines (cite) called for mammography screening beginning at age 40, the 
2010 Census used age groups 25-34 and 35-44. We chose to use women age 45 and older. Each 
patient was assigned a primary care ratio and a mammography center ratio based on their county 
of residence. 
 For travel time calculations, the physician and mammography centers were geocoded 
using ArcGIS 10.1. Exact office addresses were available for 8,039 of the 9,483 physicians. For 
the remaining 1,444 physicians, the population weighted centroid of the census tract associated 
with the physician’s office was geocoded. All 1,181 mammography centers had geocodable 
addresses. We used ArcGIS Network Analyst extension to calculate the driving time between the 
closest physician and mammography center and the population weighted centroid of every 
census block group in the study region. For reference, census block groups are generally 
composed of between 600 and 3,000 people. Each patient was assigned a travel time to their 
closest primary care physician and mammography center based on the census block group of 
their residence.  
 More detailed methodological explanations of the 2SFCA method are described 
elsewhere (McGrail, 2012). To complete the first step of the 2SFCA, we created service provider 
to population ratios using each provider and the sum of all the census block group populations 
(or populations of females 45 and older for mammography centers) within that provider’s 
catchment area. Catchment areas were set to 60 minutes to reflect the rural nature of Appalachia 
(McGrail & Humphreys, 2009). Step two then moved to each block group population center and 
identified all service providers within the designated 60 minute catchment around that block 
group. The step one ratios within each population’s catchment were summed, resulting in each 
block group having a primary care access score and a mammography center access score.  
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 Two critiques of the original 2SFCA method are its failure to vary catchment sizes based 
on population needs and its failure to account for distance decay within catchments (Luo & 
Whippo, 2012). We added a distance decay function by breaking catchments into four time 
zones: 0-10 minutes, 11-20 minutes, 21-30 minutes, and 31-60 minutes (Luo & Whippo, 2012). 
Two sets of weights were chosen for the distance decay function, corresponding to fast decay 
(weights 1, 0.60, 0.25, 0.05) and slow decay (weights 1, 0.80, 0.55, 0.15; McGrail, 2012). 
Distance decay was applied at both steps. 
 We also varied the catchment size at each step of the 2SFCA, using McGrail’s (2012) 
approach. At step one, the technique uses a set of rules to determine whether the distance decay 
weights are applied (thereby expanding or reducing a service provider’s coverage area). No step 
one decay weight was applied if the travel time between a provider and population was less than 
10 minutes, if the provider was one of the 25 closest (5 closest for mammography centers) to that 
population center, or if the population center had a population less than 5,000 and less than half 
the population of the service provider’s town (McGrail, 2012). For step two, catchments were 
varied by only including the closest 100 primary care physicians and only the closest 20 
mammography centers (McGrail, 2012). Thus, each census block group in the study region was 
given an original 2SFCA score without any distance decay or varied catchments, a slow decay 
2SFCA score with the variable catchment rules, and a fast decay 2SFCA score with the variable 
catchment rules. Patients were matched to 2SFCA scores by the census block group of their 
address. 
 Demographic and Additional Independent Variables. We included age, insurance status, 
race/ethnicity, and county economic status along with the spatial access measures for the late 
stage breast cancer diagnosis model. Age was categorized as younger than 50, 50-64, or 65 or 
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older. Insurance status was split into five categories: private, Medicare, Medicaid, uninsured, and 
unknown. Race/ethnicity was defined as white, black, or Hispanic/other. We used the Appalachia 
Regional Commission’s (ARC) designation for labeling counties as either attainment, 
competitive, transitional, at-risk, or distressed (ARC, 2012). The ARC uses the three-year 
average unemployment rate, the per capita market income, and the poverty rate to calculate an 
average for every county in the nation, and then ranks each county into quintiles to yield the final 
economic status descriptor. 
 When creating the model for receipt of adjuvant hormonal therapy, we included age, 
race/ethnicity, county economic status, cancer stage, and comorbidity index along with the 
spatial access measures. Age was defined as 65-69, 70-74, 75-79, and older than 80.. , 
Race/ethnicity and county economic status were defined as described in the above model. Cancer 
stage was categorized as stage I, II, or III, reflecting those patients eligible for adjuvant hormonal 
therapy. The Charlson Comorbidity Index, which creates a weighed score of comorbidity, was 
constructed from Medicare claims data (D’Hoore et al., 1996).  
DATA ANALYSIS 
 Initial exploratory analysis and goodness-of-fit statistics were used to determine which 
spatial access and demographic variables to include in the logistic regression models predicting 
late stage breast cancer diagnosis and receipt of adjuvant hormonal therapy (Fotheringham et al., 
2002; Windle et al., 2010). Goodness-of-fit statistics included the corrected Akaike’s 
Information Criterion (AICc) and the area under the receiver operating characteristic curve 
(AUC). AICc values lower than 3 indicate better model fit (Windle et al., 2010). An AUC value 
of 1 indicates that a model perfectly predicts the dependent variable, while an AUC value of 0.5 
indicates random chance (Zou et al., 2007). Adjusted R squared, a measure of variation 
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explained by the chosen predictor variables, was also used to compare models (Fotheringham et 
al., 2002). 
 Once an appropriate model was specified for the traditional logistic regression and the 
logistic GWR, we looked for evidence of spatial non-stationarity of the predictor variables. 
Briefly, GWR includes geographic coordinates at each study observation to construct a series of 
local regressions, resulting in unique predictor coefficients at each study observation. Traditional 
global logistic regression creates one coefficient for each predictor variable that is assumed to be 
stationary across the entire study region. We used a fixed Gaussian kernel type and the golden 
selection search to minimize the AICc when selecting bandwidth size for the logistic GWR. 
GWR 4.0 software was used for the logistic GWR (available at 
https://geodacenter.asu.edu/gwr_software). Fotheringham et al. (2002) provide a more detailed 
methodological overview of the GWR approach.  
 We also examined descriptive statistics of the local coefficients in the logistic GWR to 
identify large minimum to maximum ranges, existence of both positive and negative coefficient 
values, skewness, or any other indicators of spatial non-stationarity. When spatial non-
stationarity was found, we mapped the coefficients onto the geographic study area to examine 
varying geographic effects of each predictor variable.   
 
4.4 Results 
 There were 15,299 women living in Appalachia counties of PA, OH, KY, and NC 
diagnosed with breast cancer between years 2006 and 2008. Table 4.1 provides descriptive and 
chi-square statistics of the study variables characterized by early and late stage breast cancer 
diagnosis. The majority of women had early stage diagnosis (78.8%), were older than 65 (mean 
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age = 71.1, SD = 10.4), and were insured by Medicare (65.5%). Although race/ ethnicity was not 
included in Table 1, most women were white (95.3%). Race/ethnicity was not associated with 
stage at diagnosis (X2 = 4.26, p = 0.119). The fast decay 2SFCA scores for primary care and 
mammography centers showed a stronger relationship to stage of diagnosis than slow decay and 
original 2SFCA scores in both chi-square analysis and subsequent regression modeling, and for 
brevity are the only 2SFCA scores shown in Table 4.1. 2SFCA scores are broken into quintiles 
for ease of interpretation, with larger scores (and larger quintiles) indicating greater spatial 
access to care.   
 Table 4.2 provides descriptive and chi-square statistics characterized by receipt of 
adjuvant hormonal therapy for the 834 eligible women living in Appalachia during 2007. The 
majority of women (53.1%) did not receive adjuvant hormonal therapy. Most women were white 
(97.1%), and race/ethnicity was again omitted from the table for brevity. Unlike the stage at 
diagnosis analysis, the slow decay 2SFCA scores showed a stronger relationship to receipt of 
adjuvant hormonal therapy compared to fast decay and original 2SFCA scores, and are the only 
2SFCA scores shown in Table 4.2.  
 Goodness-of-fit statistics revealed that the model with variables age, insurance status, fast 
decay 2SFCA primary care score, and county primary care to population ratio was the best 
predictor of late stage breast cancer diagnosis. Table 4.3 shows the resulting parameter estimates 
for the global logistic regression using these variables to predict stage at diagnosis. Travel time 
to the closest primary care provider was not a significant predictor in the global logistic 
regression (OR, 1.051; p = 0.241) and did not improve overall model fit. The mammography 
center spatial access scores did not fit the model as well as the primary care spatial access scores, 
as measured by AICc, AUC, and adjusted r2. 
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 Descriptive statistics for the identical logistic GWR model predicting stage at diagnosis 
are presented in Table 4.4. The range of coefficient estimates, including both positive and 
negative values for each predictor variable, suggests spatial non-stationarity across the study 
region. Goodness-of-fit statistics showed that the logistic GWR model performed better than the 
global logistic regression model when predicting late stage breast cancer diagnosis (Table 4.5). 
The logistic GWR model had a lower AICc, higher AUC, and higher adjusted r2, demonstrating 
better model performance because of spatial non-stationarity in the final predictor variables. This 
non-stationarity is displayed in Figure 4.1, where the effects of the final predictor variables 
clearly vary throughout the four state study region. 
 The model including Charlson comorbidity index, county economic status, and slow 
decay 2SFCA mammography score was the best predictor of adjuvant hormonal therapy receipt. 
The parameter estimates for the resulting global logistic regression model are shown in Table 
4.3. Travel time to the nearest mammography center (OR, 0.954; p = 0.621) and the county 
mammography center to women age 45 and older ratio (OR, 0.985; p = 0.792) did not improve 
overall model fit. Unlike the stage at diagnosis model, the mammography access scores resulted 
in a better fitting model than using primary care access scores. The receipt of adjuvant therapy 
model also used the slow decay 2SFCA score rather than the fast decay 2SFCA score, based on 
improved AICc, AUC, and adjusted r2 values. 
 Descriptive statistics for the identical logistic GWR model predicting receipt of adjuvant 
hormonal therapy are presented in Table 4.4. The smaller coefficient ranges and lack of positive 
and negative values indicate that the effect of the predictor variables were more stationary across 
the study region. Goodness-of-fit statistics demonstrated that the logistic GWR model was no 
better than the global logistic regression model in predicting receipt of adjuvant hormonal 
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therapy (Table 4.5). There were no meaningful differences between the AICc, AUC, and adjusted 
r2 values of the two approaches. As a result, we did not map the geographic variability of the 
logistic GWR parameter coefficients because we found no evidence of spatial non-stationarity in 
the predictor variables. 
 
4.5 Discussion 
 Our analysis of breast cancer patients in Appalachia PA, OH, KY, and NC found that 
over 20% of women were diagnosed with late stage breast cancer. Age and insurance status 
predicted late stage diagnosis, as well as the spatial access to care measures of fast-decay 2SFCA 
primary care score and primary care to county population ratio. In our sample, only 46.9% of 
eligible women received adjuvant hormonal therapy following breast cancer surgery. Patients’ 
comorbidity and county economic status predicted receipt of adjuvant therapy. The slow-decay 
2SFCA mammography center score also predicted receipt of adjuvant therapy. 
Methodologically, our analysis showed the superior predictive validity of the 2SFCA method 
compared with the traditional spatial access measure of driving time from patient to provider. 
We also demonstrated the necessity of considering spatial non-stationarity across study areas. A 
GWR approach was more appropriate for our late stage diagnosis model than a traditional global 
regression. 
 Previous research using similar early (0-II) and late (III-IV) stage classification found late 
stage breast cancer diagnosis in anywhere from 13 percent of cases in Kentucky (Huang et al., 
2009), 16.7 percent of cases in Georgia (Markossian & Hines, 2012), and 17.3 percent of cases 
in Appalachia counties of Pennsylvania, Ohio, and Kentucky (Anderson et al., 2014). The 
national average from Surveillance, Epidemiology, and End Result data is 16 percent (SEER, 
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2012). Our 21.2 percent finding continues the trend of increased late stage diagnosis in 
Appalachia. 
 Prior research was inconclusive as to whether spatial access to care increased risk of late 
stage diagnosis, with some research (Huang et al., 2009) finding that greater travel time to 
mammography centers did increase risk, while other research (Henry et al., 2011; Lian et al., 
2012) found no increase due to longer travel times. Our work adds clarity by using a more 
advanced spatial access method than travel time, the 2SFCA method, and by including access to 
primary care instead of only mammography centers. For our study population, a fast-decay 
2SFCA primary care score was a better predictor of late stage diagnosis than 2SFCA 
mammography scores, travel time to mammography centers, or travel time to primary care 
providers. This result supports the finding that primary care providers are often a crucial gateway 
to breast cancer care (Roetzheim et al., 2012). We also found that lower primary care to county 
population ratios predicted late stage diagnosis. This ratio may reflect the increased risk of late 
stage diagnosis among lower socioeconomic groups (Ruffin et al., 2000), as it was strongly 
correlated with county economic status (p < 0.001). 
 Only 46.9 percent of eligible women in our sample received adjuvant hormonal therapy 
of tamoxifen, anastrozole, letrozole, or exemestane. This is considerably lower than the 67 
percent reported for an analysis of patients in California, Florida, Illinois and New York (Yen et 
al., 2007), and the 64 percent reported in an analysis of low-income patients throughout North 
Carolina (Kimmick et al., 2009). Again, the 2SFCA method was a better predictor of adjuvant 
hormonal therapy than travel time. In this model, slow decay 2SFCA mammography scores were 
a better predictor of treatment than primary care 2SFCA scores. We hypothesize that it is access 
to these more specialized cancer care services, rather than primary care providers, that impact 
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later stages of care, such as our measure of adjuvant hormonal therapy. Previous research has 
found that access to specialized cancer care services improves cancer outcomes and reduces 
treatment complications (Hill et al., 2000).  
 There are both methodological and clinical strengths to this study. To the best of our 
knowledge, this is the first study that uses the more advanced 2SFCA method to measure spatial 
access to care in Appalachia. Because Appalachia is largely rural and mountainous, and many 
areas experience physician shortages (Halverson et al., 2004), accurately measuring spatial 
access to care is essential. Another strength was our GWR approach. Logistic GWR allowed us 
to visualize the varying effects of our included predictor variables, such as the finding that 
having Medicaid, being uninsured, or having an unknown insurance status are more important 
predictors of late stage diagnosis in northeastern PA than 2SFCA scores. Clinically, our study 
benefits from the inclusion of both access to primary care services and mammography centers. 
Access to care is multifaceted, with variables contributing differentially depending on the 
outcome or treatment pattern studied (Wang & Luo, 2005). 
 There are also important limitations to the study. We were not able to obtain provider 
data for states bordering our study area. We did include bordering populations when calculating 
the 2SFCA scores, but additional provider data would have further reduced any edge effects in 
our spatial access calculations. Additionally, we used the closest provider and mammography 
centers to patients, not the actual service providers. For patients with more restrictive or no 
insurance, this could represent a significant discrepancy. We also did not include non-automobile 
transportation, which is possible to account for in the 2SFCA method (Mao & Nekorchuk, 2013.  
 Overall, we found disparities in diagnosis and treatment patters in our sample of breast 
cancer patients in Appalachia. The 2SFCA method offered the best predictive ability of the 
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spatial access measures we used and should be included whenever measuring access to care in 
Appalachia. Geographic weighted regression was useful in identifying spatial non-stationarity in 
our model predicting late stage breast cancer diagnosis. Further qualitative research is needed to 
understand the range of factors that reduce access to care. Additional research is also needed to 
identify the clinical decisions that lead to reduced rates of adjuvant hormonal therapy among 
women in Appalachia.  
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Factors Total cases % % Early stage % Late Stage p ‐value
15,299 78.8 21.2
Age
    <50 501 3.3 64.5 35.5 <0.001
    50 ‐ 64 3,242 21.2 80.9 19.1
    65+ 11,556 75.5 78.8 21.2
Insurance Status
    Private 4,309 28.2 81.8 18.2 <0.001
    Medicare 10,027 65.5 78.6 21.4
    Medicaid 544 3.6 71.1 28.9
    Uninsured 112 0.7 68.8 31.3
    Unknown 307 2 59.3 40.7
County Economic Status
    Attainment 0 0 0 0 <0.001
    Competitive 3,351 21.9 80.6 19.4
    Transitional 9,519 62.2 78.7 21.3
    At‐risk 1,482 9.7 78.3 21.7
    Distressed 947 6.2 73.5 26.5
Driving Time to Closest Primary Care (minutes)
    <10 13,010 85.0 79.2 20.8 0.031
    10 ‐ <20 1,863 12.2 76.8 23.2
    20 ‐ <30 383 2.5 74.2 25.8
    30 ‐ <40 41 0.3 85.4 14.6
    40 ‐ <50 1 <0.001 100 0
    50+ 1 <0.001 100 0
Driving Time to Closest Mammography Center (minutes)
    <10 9,332 61.0 79.3 20.7 0.337
    10 ‐ <20 4,008 26.2 78.3 21.7
    20 ‐ <30 1,417 9.3 76.7 23.2
    30 ‐ <40 422 2.8 79.4 20.6
    40 ‐ <50 97 0.6 78.4 21.6
    50+ 23 0.2 82.6 17.4
Ratio of Primary Care Physicians / County Population
    1st Quintile 3,104 20.3 75.9 24.1 <0.001
    2nd Quintile 3,055 20.0 77.5 22.5
    3rd Quintile 3,065 20.0 80.0 20.0
    4th Quintile 3,364 22.0 79.3 20.7
    5th Quintile 2,711 17.7 81.4 18.6
Ratio of Mammography Centers / County Population of Females 
Age 45 and older
    1st Quintile 3,185 20.8 79.3 20.7 <0.001
    2nd Quintile 3,050 19.9 81.9 18.1
    3rd Quintile 3,352 21.9 78.6 21.4
    4th Quintile 2,735 17.9 77.4 22.6
    5th Quintile 2,977 19.5 76.4 23.6
2SFCA Fast Decay Scores to Primary Care
    1st Quintile 3,059 20.0 76.4 23.6 <0.001
    2nd Quintile 3,060 20.0 79.0 21.0
    3rd Quintile 3,063 20.0 80.5 19.5
    4th Quintile 3,057 20.0 78.1 21.9
    5th Quintile 3,060 20.0 79.9 20.1
2SFCA Fast Decay Scores to Mammography Centers
    1st Quintile 3,060 20.0 79.0 21.0 0.130
    2nd Quintile 3,061 20.0 79.6 20.4
    3rd Quintile 3,060 20.0 79.7 20.3
    4th Quintile 3,061 20.0 77.4 22.6
    5th Quintile 3,057 20.0 78.2 21.8
2SFCA, Two‐Step Floating Catchment Area
Table 4.1. Characteristics of study patients by breast cancer stage at diagnosis.
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Factors Total cases % % Had AT % No AT p ‐value
834 46.9 53.1
Age
    65 ‐ 69 172 20.6 48.8 51.2 0.159
    70 ‐ 74 195 23.4 40.5 59.5
    75 ‐ 79 208 24.9 51.4 48.6
    80+ 259 31.1 46.7 53.3
Charleson Comorbidity Index
    0 535 64.1 43.9 56.1 0.110
    1 199 23.9 52.8 47.2
    2 57 6.8 47.4 52.6
    3+ 43 5.2 55.8 44.2
County Economic Status
    Attainment 0.0 0.0 0.0 0.0 0.025
    Competitive 110 13.2 40.0 60.0
    Transitional 571 68.5 45.9 54.1
    At‐risk 100 12.0 51.0 49.0
    Distressed 53 6.4 64.2 35.8
Driving Time to Closest Primary Care (minutes)
    <10 706 84.7 47.3 52.7 0.386
    10 ‐ <20 99 11.9 44.4 55.6
    20 ‐ <30 26 3.1 50.0 50.0
    30 ‐ <40 3 0.4 0.0 100.0
    40 ‐ <50 0 0.0 0.0 0.0
    50+ 0 0.0 0.0 0.0
Driving Time to Closest Mammography Center (minutes)
    <10 522 62.6 46.9 53.1 0.576
    10 ‐ <20 201 24.1 48.8 51.2
    20 ‐ <30 81 9.7 40.7 59.3
    30 ‐ <40 22 2.6 54.5 45.5
    40 ‐ <50 6 0.7 50.0 50.0
    50+ 2 0.2 0.0 100.0
Ratio of Primary Care Physicians / County Population
    1st Quintile 174 20.9 49.4 50.6 0.609
    2nd Quintile 157 18.8 48.4 51.6
    3rd Quintile 174 20.9 46.0 54.0
    4th Quintile 168 20.1 48.8 51.2
    5th Quintile 161 19.3 41.6 58.4
Ratio of Mammography Centers / County Population of Females 
Age 45+
    1st Quintile 170 20.4 40.0 60.0 0.339
    2nd Quintile 176 21.1 50.6 49.4
    3rd Quintile 183 21.9 47.0 53.0
    4th Quintile 141 16.9 48.2 51.8
    5th Quintile 164 19.7 48.8 51.2
2SFCA Slow Decay Scores to Primary Care
    1st Quintile 165 19.8 40.6 59.4 0.259
    2nd Quintile 172 20.6 45.9 54.1
    3rd Quintile 162 19.4 53.1 46.9
    4th Quintile 166 19.9 48.2 51.8
    5th Quintile 169 20.3 46.7 53.3
2SFCA Slow Decay Scores to Mammography Centers
    1st Quintile 168 20.1 41.1 58.9 0.037
    2nd Quintile 172 20.6 42.4 57.6
    3rd Quintile 162 19.4 51.9 48.1
    4th Quintile 167 20.0 44.3 55.7
    5th Quintile 165 19.8 55.2 44.8
2SFCA, Two‐Step Floating Catchment Area
Table 4.2. Characteristics of study patients by receipt of adjuvant hormonal therapy (AT).
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Variable* β     s.e. z‐statistic Sig. Exp(β) 95% C.I. for Exp(β)
Intercept ‐1.151 0.123 88.267 <0.001 0.316
Age ‐0.146 0.038 15.103 <0.001 0.864 0.803 ‐ 0.930
Insurance Status 0.276 0.026 110.749 <0.001 1.318 1.252 ‐ 1.388
2SFCA score‐ Primary Care, Fast Decay ‐0.036 0.014 7.509 0.006 0.962 0.935 ‐ 0.989
County Primary Care / Population Ratio ‐0.056 0.014 14.837 <0.001 0.946 0.919 ‐ 0.973
Variable+ β     s.e. z‐statistic Sig. Exp(β) 95% C.I. for Exp(β)
Intercept ‐1.431 0.353 16.464 <0.001 0.239
Charlson Comorbidity Index 0.168 0.084 3.948 0.047 1.183 1.002 ‐ 1.395
County Economic Status 0.280 0.101 7.620 0.006 1.323 1.085 ‐ 1.615
2SFCA score ‐ Mammography Center, Slow Decay 0.115 0.050 5.340 0.021 1.122 1.018 ‐ 1.236
2SFCA, Two‐Step Floating Catchment Area
Table 4.3. Parameter estimates for the global logistic regression model predicting late stage breast cancer diagnosis* and receipt of adjuvant 
hormonal therapy+.
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Variable* Minimum 1st Quartile Median 3rd Quartile Maximum
Intercept ‐4.532 ‐1.860 ‐1.276 ‐0.709 1.725
Age ‐1.090 ‐0.229 ‐0.126 ‐0.078 0.389
Insurance Status ‐0.104 0.231 0.299 0.370 0.883
2SFCA score ‐ Primary Care, Fast Decay ‐0.522 ‐0.083 ‐0.020 0.023 0.408
County Primary Care / Population Ratio ‐1.806 ‐0.078 ‐0.022 0.057 0.465
Variable+ Minimum 1st Quartile Median 3rd Quartile Maximum
Intercept ‐1.555 ‐1.437 ‐1.318 ‐1.287 ‐1.261
Charlson Comorbidity Index 0.131 0.155 0.181 0.186 0.193
County Economic Status 0.217 0.237 0.252 0.291 0.324
2SFCA score ‐ Mammography Center, Slow Decay 0.100 0.102 0.105 0.108 0.121
2SFCA, Two‐Step Floating Catchment Area
Table 4.4. Summary statistics of the parameter estimates for the logistic GWR models for late stage breast cancer diagnosis*a 
and receipt of adjuvant hormonal therapy+b.
a 36.9 km bandwidth
b 541.5 km bandwidth
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Model* n k e ‐2 log likelihood AICc         AUC ± s.e. r 2 (adj.)
Global Logistic 15,299 5.0 15,670.6 15,680.6 0.562 ± 0.006 0.009
GWR 15,299 144.1 15,299.6 15,590.5 0.623 ± 0.006 0.033
Model+ n k e ‐2 log likelihood AICc AUC ± s.e. r 2 (adj.)
Global Logistic 834 4.0 1,135.0 1,143.0 0.583 ± 0.20 0.016
GWR 834 5.2 1,133.4 1,143.9 0.587 ± 0.20 0.017
Table 4.5. Comparison of fit between global logistic regression and GWR models for late stage breast cancer 
diagnosis*a and receipt of adjuvant hormonal therapy+b.
n, number of patients; ke, effective number of parameters; AICc, corrected Akaike's Information Criterion; AUC, area 
under the receiver operating characteristic curve.
a 36.9 km bandwidth
b 541.5 km bandwidth
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CHAPTER 5 
Overall Conclusion 
 
5.1 Research Question 
 The Appalachia region of the U.S. suffers from numerous socioeconomic disparities 
(Pollard & Jacobsen 2013), increased incidence and mortality for many cancers (Blackley, 
Behringer, & Zheng, 2012; Winger et al., 2003), and substandard cancer screening and treatment 
patterns (Freeman, Huang, & Dragun, 2012; Hall et al., 2002). Cumulatively, these disparities 
suggest the region has reduced access to health care (Paskett et al., 2011). Geographic 
information systems (GIS) technologies and the methodology used to measure spatial access to 
care, meanwhile, have grown from relatively simple techniques to more sophisticated approaches 
that provide increased geographic specificity and more realistic assumptions about patient 
healthcare utilization (McGrail, 2012; Wang, 2012). Nonetheless, despite Appalachia’s need, 
these technologies have not been evaluated in the region. 
 
5.2 Research Goals 
 This dissertation focused on the methodology used to measure spatial access to 
healthcare. The study region included four states in Appalachia: Pennsylvania, Ohio, Kentucky, 
and North Carolina. Traditional methods—including provider to population ratios and travel time 
between populations and providers—were evaluated in conjunction with the more advanced 
techniques of the two-step floating catchment area (2SFCA) method and the spatial access ratio 
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(SPAR) method. Spatial access was computed in reference to primary care physicians as well as 
to mammography centers. The goal was to compare and contrast what each method said about 
the resulting spatial access to care in the study region. Also, within the 2SFCA and SPAR 
methods, I  evaluated the different parameters of each method among which researchers need to 
choose. Finally, the dissertation used the resulting spatial access scores to predict cases of late 
stage breast cancer diagnosis and  
 
5.3 Study Results 
 In chapter two, spatial access to mammography centers was mapped across the entire 
states of PA, OH, KY, and NC. The larger urban areas were all within 10 minutes of their closest 
mammography centers, while the most rural areas of north central PA, southeastern OH, and 
eastern KY consistently traveled over 40 minutes to their closest mammography centers. 
Provider to population ratios—found by dividing the number of mammography centers in a 
county by the total population of county women age 45 and older—varied widely throughout the 
study area. The county boundaries proved problematic,  as many adjacent counties had 
drastically different scores. Each of the 2SFCA measures were strongly correlated with each 
other. The original 2SFCA method showed the highest spatial access scores in many of the major 
urban areas of the study region. However, adding distance decay functions and varying the 
catchment sizes of the 2SFCA decreased access scores around many of those same urban areas 
and increased scores in many smaller, rural areas. Eastern Kentucky, for example, had some of 
the highest modified 2SFCA scores, likely due to their small population numbers and even 
distribution of mammography centers. Spatial access was also compared within rural and urban 
census block groups. Rural areas in each state had longer travel times to their closest 
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mammography center, but also had larger provider to population ratios because of their reduced 
population. The 2SFCA scores were moderately higher for urban census block groups in PA, 
OH, and NC, while the rural block groups in KY generally had higher 2SFCA scores. When 
comparing spatial access between Appalachia and non-Appalachia areas of the same states, a 
similar pattern emerged to the urban-rural comparison. Appalachia regions had longer travel 
times to their closest mammography center but also had larger provider to population ratios. The 
2SFCA access scores did not show a clear divide between Appalachia and non-Appalachia areas, 
though, with Appalachia areas having higher scores in PA and KY and non-Appalachia areas 
having higher scores in NC and OH. Overall, the SPAR technique was recommended because it 
minimized the difference in scores when deciding between which distance decay weight or 
variable catchment method to choose. 
In Chapter three, spatial access to primary care physicians was mapped across the 
Appalachia regions of PA, OH, KY, and NC. Unlike travel times to closest mammography 
centers, most census block groups throughout the study region were less than 10 minutes from 
their closest primary care physicians. There was a clear pattern of relationships between each of 
the spatial access measures when measuring access to primary care physicians. Closest travel 
time and provider to population ratios were both more strongly correlated with the 2SFCA 
measures that did not include variable catchment sizes: the original 2SFCA, the slow decay 
weight 2SFCA, and the fast decay weight 2SFCA. These 2SFCA measures were also more 
strongly correlated with each other. Comparatively, the 2SFCA measures that included variable 
catchment sizes—slow decay, variable catchment size 2SFCA; fast decay, variable catchment 
size 2SFCA; and continuous decay, variable catchment size 2SFCA—were less strongly 
correlated with closest travel times, provider to population ratios, and the other 2SFCA 
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measures, but were more strongly correlated with each other. When mapping 2SFCA scores 
across the study region, the same distinction occurred based on whether variable catchment sizes 
were included. Without variable catchments, and thus without any limit on the theoretical 
number of physicians a population could access, several of the largest urban areas in the study 
region had the highest 2SFCA scores, including Pittsburgh, Youngstown, and Greensboro. After 
adding rules to vary catchment sizes and cap the number of physicians a population could access, 
these same areas saw drops in their 2SFCA scores, while more rural areas of eastern KY and 
central PA had increased scores. Similar to access to mammography centers, rural census block 
groups had a longer average travel time to their closest primary care physician than urban census 
block groups. Of the four study states, KY had the longest travel times. Even Kentucky’s urban 
block groups had longer travel times (9.54 min.) than the rural block groups of PA (7.50 min.) 
and OH (8.26 min.). There were also similarities to the rural-urban 2SFCA score divide in the 
mammography research when comparing the 2SFCA access scores to primary care physicians 
between rural and urban block groups. The 2SFCA scores were again moderately higher for 
urban areas in PA, OH, and NC, while the rural block groups in KY generally had higher 2SFCA 
scores. It is important to note that the urban classification also included suburban areas, for ease 
of interpretation. Chapter three also recommended using the SPAR score because it had a 
generally normalizing effect of 2SFCA scores when deciding between which decay weight and 
which variable catchment parameters to choose. 
In Chapter four, spatial access scores to mammography centers and primary care 
physicians were used to predict two important clinical outcomes in breast cancer treatment: stage 
at diagnosis and receipt of guideline concordant adjuvant hormonal therapy. Similar to Chapter 
three, this research focused only on Appalachia areas of PA, OH, KY, and NC. For the 20% of 
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women who were diagnosed with late stage breast cancer (stages III-IV), the demographic 
variables that predicted late stage diagnosis were a younger age and having an insurance status of 
Medicaid, uninsured, or unknown insurance. The spatial access to care measures of fast decay 
2SFCA primary care score and primary care to county population ratio also predicted late stage 
diagnosis. Those access to care measures were better predictors of late stage diagnosis than 
travel time to a patient’s closest primary care provider or any of the spatial access to 
mammography center measures. Geographically weighted regression demonstrated that the 
effect of these predictor variables on late stage diagnosis varied throughout the study region, 
highlighting the importance of considering spatial non-stationarity when employing regression 
models across large geographic areas. The demographic variables of comorbidity status and 
county economic status predicted whether patients received the recommended adjuvant hormonal 
therapy after breast cancer surgery. The spatial access to care score from the slow decay 2SFCA 
method in reference to mammography centers also predicted receipt of adjuvant therapy. The 
mammography 2SFCA measure was a better predictor than the other mammography center 
spatial access scores of closest travel time or provider to population ratio, and it was also a better 
predictor than any of the primary care spatial access measures. According to geographically 
weighted regression analysis, the effect of the predictor variables on the dependent variable of 
receipt of adjuvant therapy did not vary throughout the study region, unlike in the late stage 
diagnosis model. Overall, Chapter four demonstrated the effectiveness of the 2SFCA method in 
predicting important clinical indicators. The chapter also demonstrated the necessity of 
considering spatial non-stationarity when predicting clinical outcomes and treatment patterns 
across large geographic areas. 
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5.4 Limitations of the Study 
 There were several limitations to this dissertation research. Methodologically, the 
research would have benefited from including mammography centers and primary care 
physicians that bordered the study area. Neighboring population data for use when calculating 
2SFCA scores was included, but several populations in the study area are likely served by health 
providers outside of the study area. For example, rural areas along the Pennsylvania-New York 
border in northeastern PA likely utilize healthcare providers in the small city of Binghamton, 
New York, less than 20 minutes from the state border. Because of data permissions, however, we 
were not able to include Binghamton’s mammography centers and primary care physicians in the 
analyses. Another methodological limitation was the lack of non-automobile transportation 
options. In several of the urban areas of the study region, particularly the greater Philadelphia 
area, walking, riding bicycle, and using public transportation likely constitute a large portion of 
travel for certain population groups. Therefore, the most accurate 2SFCA catchment size for 
these populations is likely less than the maximum of 60 minutes used throughout the dissertation. 
Another limitation, most relevant to Chapter four, was the use of the closest mammography 
center or primary care physician rather than the healthcare provider that each patient actually 
uses. Patients with fewer provider choices because of more restrictive or no insurance may travel 
considerably farther for healthcare than to their closest geographic provider. 
 
5.5 Future Research Possibilities 
 This dissertation work suggests numerous possibilities for further research. When 
comparing between different 2SFCA distance decay weights and methods to vary catchment 
sizes, it would be informative to include patient healthcare utilization behavior to guide the 
105 
choice of 2SFCA parameters. There would likely be interaction effects with socioeconomic 
status and automobile ownership as well. For example, urban, economically distressed 
populations that do not own automobiles might have faster decay weights and smaller catchment 
sizes (i.e., their travel impediment is greater and total length of distance they are able to travel for 
healthcare is shorter). A mixture of population-level demographic data (e.g., U.S. Census) could 
be used to estimate car ownership. Health insurance claims data could be used to identify how 
far patients are actually traveling for different healthcare providers. Qualitative data would also 
be helpful to identify patient preferences and the socioeconomic factors that interact with 
healthcare travel decisions. In reference to the clinical indicators studied in Chapter four, more 
research is needed to understand the range of factors that influence late stage breast cancer 
diagnosis. This dissertation further refined how spatial access to care impacts the likelihood of 
late stage diagnosis, but the interactions between spatial access and socioeconomic variables 
needs further exploration. Similarly, the research in Chapter four found that only 46.9 percent of 
eligible women in our sample received adjuvant hormonal therapy. Qualitative research and 
detailed patient clinical history reviews would be helpful to understand the low rate of 
recommended adjuvant therapy. 
  
5.6 Overall Study Impact 
 In conclusion, this dissertation provided a template for future public health research 
examining spatial access to care in Appalachia. Researchers in Appalachia can now make more 
informed decisions about which spatial access measures to employ, how to apply the various 
parameters of each measure, and how to interpret the resulting map of spatial access scores. 
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Additionally, this dissertation provided an example of how spatial access can be incorporated 
into models predicting cancer outcomes and treatment patterns of interest.  
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